Site Saturation Mutagenesis of Residue 71 in β-Lactamase by Schultz, Steve Chester
SITE SATURATION MUTAGENESIS OF 
RESIDUE 71 IN B-LACTAMASE 
Thesis by 
Steve Chester Schultz 
In Partial Fulfillment of the Requirements 
for the Degree of 
Doctor of Philosphy 
California Institute of Technology 
Pasadena, California 
1986 
(Submitted April 14, 1986) 
ii 
ACKNOWLEDGEMENT 
• I would like to thank my advisor, Dr. John H. Richards 
for his encouragement and support. His creativity and aca-
demic insight have influenced me tremendoulsy. 
I wish to thank Suzanne Horvath for her guidance, help, 
and steadfast friendship during my years at Caltech. Special 
thanks also go to Gloria Dalbadie-McFarland and Jim Neitzel 
for their many hours of patient assistance and helpful dis-
cussions as well as for many hours of enjoyment in more 
social pursuits. 
I wish to thank the Richards' group; I am deeply grate-
ful for contributions by each member of this uniquely tal-
ented and supportive group. Along with Gloria and Jim, 
special thanks go to Steve Carroll, Sheila Iverson, Bill 
Healy, and Tom Chang. 
I am also deeply grateful to Dr. Jerry R. Mohrig of 
Carleton College; his expert guidance, encouragement, and 
enthusiasm initiated my interest in research. 
I would like to express my appreciation to Wayne 
McFarland for his friendship, support, and encouragement as 
well as for many enjoyable and fruitful social endeavors; to 
Brenda Baldwin-Zuschke for her friendship and support, 
especially during our early years at Caltech; and to Rosa 
Oefinger and Ruth (Cathy) Duborow for their friendship, 
encouragement and all the fun times. 
Finally, I am deeply grateful to my family for their 
iii 
support and encouragement: my mother and father, Ken and 
Wanda Schultz; my brothers Dan, Tim, and Jay; my sister 
Beth; my sister-in-law Darcey; and my nephews Nicholas and 
Matthew. Their love made it all possible. 
My work was supported by NIH Grant GM 16424, NIH-NRSA 
Traineeship 5 T32 GMO 7616-08, and the William Barton Jones 
Fellowship. 
iv 
SITE SATURATION MUTAGENESIS OF 
RESIDUE 71 IN B-LACTAMASE 
Abstract 
A method was developed to "saturate" a particular resi-
due in a protein with all possible amino acid substitutions. 
The method essentially involves introducing into the gene at 
the codon for the residue of interest a mixture of nucleo-
tides: A,C,G, and T at the first two positions, c and G at 
the third position. This mixture of oligonucleotides can be 
readily introduced into the gene as a cassette when restric-
tion sites are conveniently nearby. This method was used to 
saturate residue 71 in the pBR322 encoded B-lactamase. The 
first step was introduction of restriction sites into pBR322 
that flank the codon for residue 71: an Ava I site at 3972 
and a Sea I site at 3937. The DNA fragment between these 
residues was removed and replaced with a mixture of synthetic 
double-stranded oligonucleotides that included 32 codons for 
residue 71 (codons for all 20 amino acids and the amber 
codon). The method was nearly 100% efficient for introducing 
this set of mutations and the observed distribution of codons 
indicates that the various codons were introduced at equal 
frequencies. 
Class A B-lactamases, which include the pBR322 encoded 
enzyme, contain a conserved triad (Ser-Thr-x-Lys) at the 
catalytic site; this site includes Ser 70 whose hydroxyl 
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group opens the B-lactam ring. This study focuses on the 
conserved Thr 71, whose role in the activity of B-lactamase 
was previously unknown. Mutants with all 19 possible amino 
acid substitutions at residue 71 were generated as described 
above and characterized by the in vivo penam and cephem 
antibiotic resistance they provided to E. coli LS-1 cells. 
surprisingly, cells producing any of 14 of the mutant enzymes 
display appreciable resistance to ampicillin; only cells with 
mutants having Tyr, Trp, Asp, Lys, or Arg at residue 71 had 
no observable resistance to ampicillin. However, all of 
the mutants are less stable to cellular proteases than the 
wild type enzyme. These results suggest that Thr 71 is not 
essential for binding or catalysis but is important for 
stability of the B-lactamase protein. An apparent change in 
the substrate specificity of the various mutant enzymes 
indicates that residue 71 influences the region of the 
protein that accommodates the side chain attached to the 
B-lactam ring of the substrate. 
To study the role of the naturally occurring disul-
fide bond in stabilizing B-lactamases that contain mutations 
at residue 71, a Cys 77 --> Ser mutation was introduced into 
all 19 of these mutants. The resulting doubly mutant pro-
teins were analyzed for their ability to confer resistance 
to ampicillin in vivo and the relative quantities of the 
mutant enzymes in whole cell extracts were analyzed by anti-
body stains of electrophoretic blots. Although the activity 
and stability of the single mutant Cys 77 --> Ser is indis-
vi 
tinguishable from the wild type enzyme in physiological 
conditions, the doubly mutant proteins are much less stable 
than the analagous single mutants that contain a disulfide 
bond. Apparently, the presence of the disulfide bond in 
B-lactamase enables the enzyme partially to overcome insta-
bilities arising from mutations at residue 71. The results 
presented here also demonstrate that Thr at residue 71 per-
forms a unique and essential role in the stability of B-lac-
tamase. 
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Proteins can perform many diverse functions because 
of their ability to assume unique structures that position 
various chemical groups into precisely defined three-dimen-
sional arrangements such that these groups can interact with 
other molecules in very specific ways. However, precise 
mechanisms by which proteins can fold to generate unique 
structures remain unclear as do the precise interactions by 
which the resulting arrangement of chemical groups can give 
rise to a particular function. Discovering the underlying 
principles of the relationships between structure and func-
tion in proteins is currently among the most basic and inter-
esting areas of protein biochemistry. 
Biophysical techniques such as protein crystallography, 
nuclear magnetic resonance spectroscopy, circular dichroism, 
and florescence spec~roscopy provide many insights into 
structure-function relationships in proteins. By using such 
techniques to examine thoroughly particular structures andjor 
functions, we can learn what conformations a protein assumes, 
which functional groups interact with other groups, and what 
chemical pathways a reaction utilizes. Although such studies 
can elucidate many aspects of the relationships between 
structure and function, several features cannot be studied by 
investigating only existing structures. 
Methods for producing specific changes in protein struc-
ture would complement such biophysical studies by allowing 
one to investigate how changes in structure affect function. 
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Until recently, obtaining stuctural variants of proteins was 
difficult; one could isolate naturally occurring variants 
from different organisms or individuals (as for cytochrome c 
and hemoglobin) or produce structural variants by chemical 
modification or random mutagenesis. Obtaining specified 
structural variants was often impossible using these meth-
ods. Presently, however, by utilizing modern techniques for 
site-specific in vitro mutagenesis, one can produce any 
of 19 possible structural variants at any residue in a pro-
tein. This ability to produce any desired mutation allows a 
rational study of the relationships between structure and 
function in proteins. Just as organic chemists could ration-
ally study the nature of carbocations by synthesis and char-
acterization of many different molecules and, likewise, study 
factors influencing specificity in electrophilic aromatic 
substitution by synthesis and characterization of numerous 
aromatic structures, site-specific mutagenesis allows protein 
biochemists to produce and characterize large numbers of 
structural variants to learn what basic principles govern 
structure and function in proteins. 
since the introduction of site-specific mutagenesis 
as an approach for studying structure-function relation-
ships in 1982 (1,2), many such studies have been reported. 
This approach has been used to study the roles of specific 
residues in catalysis for tyrosyl-tRNA synthetase (2,3,4), 
alkaline phosphatase (5), lac carrier protein (6), cytochrome 
c (7), aspartate transcarbamoylase (8), triose phosphate iso-
4 
merase (9), and B-lactamase (1,10); to alter substrate speci-
ficity and affinity for trypsin (11) and tyrosyl-tRNA synthe-
tase (12); to change the pH dependence of activity for subti-
lisin (13); to study protein folding for cytochrome c (14) 
and dihydrofolate reductase (15); to study the stabilization 
of proteins by disulfide bonds for lysozyme (16,17), inter-
leukin-2 (18,19), dihydrofolate reductase (15), and B-lactam-
ase (20); to alter protein-protein interactions for tyrosyl-
tRNA synthetase (21); and to study protein-DNA interactions 
for bacteriophage 434 repressor (22) and bacteriophage P22 
mnt repressor (23). 
However, a large number of possible amino acid substitu-
tions exist. For a protein with 200 amino acid residues, 
3,800 possible single amino acid subtitutions exist; 
14,436,200 possible combinations of two amino acid substitu-
tions exist. Consequently, rational studies of structural 
variants of proteins require high levels of theory to predict 
which structures should be studied. However, prejudices 
necessarily resulting from the need to identify interesting 
mutations prior to their study may exclude certain mutations 
from studies that might generate new insights into structure-
function relationships in proteins. Moreover, since most of 
the principles governing structure and function are uncertain 
or unknown, the effects of specific amino acid substitutions 
usually are difficult to predict. Due to these limitations, 
studies of mutant proteins are restricted to well character-
ized systems for which insights are available from studies 
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such as x-ray crystallography, computer modeling, sequence 
homologies, and catalytic mechanisms; even then, surprising 
results often arise. 
Circumventing these limitations requires efficient 
methods for production and characterization of large numbers 
of structural variants. For characterization of such struct-
ural variants, if the protein in question affects the pheno-
type of cells, one can easily determine the activities of 
large numbers of mutations by screening cells for a partic-
ular function. A phenotypic screen is particularly effect-
ive if the protein is essential for cell growth; active 
mutants can then be identified from among 106 or more inac-
tive mutants. 
For producing large numbers of structural variants, 
several methods have been introduced. One approach is to 
make site-specific mutagenesis more general by using mixtures 
of oligonucleotides in procedures such as oligonucleotide 
directed mutagenesis to produce a specified set of muta-
tions. Several examples exist, including: production of 11 
different mutations at five sites in the gene for the simian 
virus 40 large-T antigen using a mixture of mutagenic primers 
that contained 1024 different sequences (24); production of 
up to five different mutations at codon 12 in the c-Ha-rasl 
gene by using mixtures of up to 8 different mutagenic primers 
(25); and production of five different mutations in the 
fibroin gene promoter by using a mixture of six different 
mutagenic primers (26). Although such methods can be used to 
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generate small sets of mutations, limitations arising from 
low and variable efficiencies make production of large sets 
of mutations difficult. 
The opposite approach is to make random mutagenesis 
more specific. Several methods of targeting random mutagen-
esis to specific areas in a gene have been reported (27) . 
More recently, long synthetic oligonucleotide segments con-
taining low levels of random base mismatches have been used 
to introduce one or two base mutations at high freqencies. 
For example, 132 single base mutations were generated in the 
mouse B-globin promoter region using the following procedure 
(28): a single stranded plasmid vector that contained the 
promoter region was mutagenized using various chemicals; an 
oligonucleotide primer was extended across this region of the 
plasmid using avian myeloblastosis virus reverse transcrip-
tase to produce DNA segments with incorrect bases; the 
desired fragment was then isolated from appropriate restric-
tion digests and inserted into a new host vector; the result-
ing plasmids were used to transform cells directly, or DNA 
fragments were enriched for single base mismatches and then 
_reincorporated into the plasmid. In another method, oligo-
nucleotide segments were synthesized to contain low levels of 
single base mismatches and ligated into the region preceding 
the iso-1 cytochrome c gene to produce various single and 
double base mutations (29). Although these methods produce 
large numbers of mutations, they do not explore all possible 
amino acid substitutions and require a very efficient selec-
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table phenotype. 
An efficient method for generating a desired set of 
many known mutations would provide an approach intermediate 
to the two methods discussed above and, therefore, would 
allow a complete set of desired structures to be investi-
gated. To study thoroughly a residue of particular interest, 
one could "saturate" a specific residue with all possible 
amino acid substitutions. A method for site saturation, 
whereby one produces and characterizes structural variants 
with all 19 amino acid substitutions at a specific residue, 
would enhance our ability to study rationally the relation-
ships between structure and function in proteins. 
If a procedure exists for efficiently generating the 
appropriate mutants and the protein in question affects the 
phenotype of cells such that one can easily screen for 
mutants that perform a particular function, one could then 
extend this approach to simultaneous saturation of two or 
more sites to assess the effects of combinations of residues 
on protein function. 
Site saturation can be accomplished by introducing 
into the gene at the codon for the residue of interest a 
mixture of nucleotides: A,C,G, and T at the first two posi-
tions; c and G at the third position. The resulting mixture 
of 32 oligonucleotides, which codes for all 20 amino acids 
and the amber codon, can be readily introduced into the gene 
as a "cassette" when restriction sites are conveniently 
nearby. If desired, appropriate mixtures of oligonucleotides 
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can be used to encode a particular subset of amino acids. 
I have used site saturation to study the role of Thr 71 
in the pBR322 encoded B-lactamase (EC 3.5.2.6) (30). B-Lac-
tamase catalyzes the hydrolysis of the B-lactam ring of penam 
and cephem antibiotics (31). This activity confers resis-
tance to these antibiotics on cells that produce the enzyme 
and thereby provides a convenient screening procedure to 
assess the activities of mutant S-lactamases. 
The class A B-lactamases (32) (which includes the pBR322 
encoded enzyme) contain a conserved triad (SerThr-x-Lys) (32) 
which includes Ser 70, whose hydroxyl group opens the B-lac-
tam ring (33,34). This study focuses on the conserved Thr 
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CHAPTER I 
A GENERAL METHOD FOR "SATURATION" OF A 
RESIDUE IN A PROTEIN WITH ALL 19 
POSSIBLE AMINO ACID SUBSTITUTIONS 
13 
Introduction 
For site saturation studies of the relationship between 
structure and function in proteins, one must first generate 
mutants with all 19 amino acid substitutions at a specific 
residue in a protein by introducing into the gene at the 
codon for the residue of interest a mixture of nucleotides 
that code for all 19 amino acids (or a subset of these 19 
amino acid substitutions if desired). The mutagenic tech-
nique used to introduce the necessary mixture of nucleotides 
must fulfill two requirements. First, the technique must 
generate the specified mutations at nearly 100% efficiency; 
the presence of non-mutated or non-specified sequences will 
greatly increase the number of clones that one must analyze. 
Second, the mutagenic technique must produce the various 
individual mutations at nearly equal frequencies; non-equiv-
alent frequencies will result in underrepresented codons and, 
therefore, amino acid substitutions that may go untested in 
the experiments. If one could efficiently generate all 19 
amino acid substitutions at equal frequencies, site 'satura-
tion could be used routinely to study the roles performed by 
particular residues in the structure and function of 
proteins. 
This approach to studies of structure-function relation-
ships in proteins becomes particularily appealing when the 
protein in question affects the phenotype of cells such that 
one can easily screen for mutants that perform a particular 
function. With an efficient technique for introducing the 
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desired set of mutations, site saturation could then be 
extended to simultaneous saturation of two or more residues 
to assess the effects of combinations of residues on protein 
function. 
In an approach commonly used for cloning and subcloning 
genes, mixtures of many fragments generated by digesting 
genomic or plasmid DNA with restriction enzymes are ligated 
into specific restriction sites of an appropriate DNA 
vector. To separate individual sequences from the large 
mixture of vector constructions that result from such a 
ligation, the sequences are incorporated into cells by trans-
formation procedures such that individual cells receive only 
one vector construction. By spreading an appropriate concen-
tration of the transformation mixture onto an agar plate, 
single cells will give rise to isolated colonies, each of 
which will contain a unique vector construction. 
This approach could be used to efficiently generate 
specified mutations if restriction sites exist in convenient 
locations in the structural gene for a protein of interest • 
• 
The DNA segment between such sites could be removed and 
replaced with a synthetic double stranded oligonucleotide 
that introduces a desired mutation. Such studies have 
recently been reported (1,2). This technique had also been 
used to introduce sets of mutations into genes (3,4,5). such 
an approach could be used for site saturation to introduce 
into the gene at the codon for the residue of interest a 
mixture of nucleotides that codes for all 20 amino acids. If 
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the mixture contains equimolar amounts of the various codons, 
this method should efficiently generate all specified muta-
tions at equal frequencies. 
Using this approach, I have saturated residue 71 in 
the pBR322 encoded B-lactamase with all possible amino acid 
substitutions (6). The significance of residue 71 will be 
discussed in Chapter II. 
Since convenient restriction sites did not exist in 
pBR322, I first introduced restriction sites that flank 
the codon for Thr 71 by oligonucleotide-directed mutagen-
esis: an Ava I site at 3972 and a Sea I site at 3937. The 
DNA fragment between these sites was removed and replaced 
with a mixture of double-stranded oligonucleotide segments. 
The segment was synthesized to contain a mixture of nucleo-
tides at the codon for residue 71: A,C,G, and T at the first 
two positions and C and G at the third position. This combi-
nation of sequences contains 32 different codons that code 
for all 20 amino acids and the amber codon. The resulting 
mixture of plasmids was used to transform E. coli and plasmid 
DNA was isolated from 108 colonies. In this collection of 
plasmids, codons for all twenty amino acids and an amber 
codon were observed. Thirty of the thirty-two codons were 
obtained; the distribution of observed codons was similar to 
that predicted by a Poisson distribution based on the intro-
duction of the various codons at equal frequencies. 
Since beginning our site saturation experiments, two 
related studies have also been published. For the c-Ha-ras1 
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gene product, eighteen mutations (the Gly 12 --> Val mutant 
was already available) were produced by oligonucleotide-
directed mutagenesis using a mixture of mutagenic primers 
(7). Proteins with all of the possible amino acid substitu-
tions at residue 12 were analyzed for their ability to induce 
morphological transformations in Rat-1 cells. In the second 
study, mutant proteins with all 19 amino acid substitutions 
at residue 222 in subtilisin were produced by an approach 
somewhat similar to ours. In four separate reactions, mix-
tures of oligonucleotides each containing five different 
codons for residue 222 were ligated into the gene (8). The 
ratios of the various mutants obtained from each of the four 
pools of oligonucleotides were severely skewed. Two of the 
twenty codons were not obtained; these were later produced 
separately. Also, 30% of the characterized plasmids con-
tained unexpected mutations. Our procedure is more reliable 
and general than either of these and, therefore, could be 
reliably used for simultaneously saturating multiple sites in 
a protein. 
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Materials & Methods 
Enzymes and Chemicals 
Restriction enzymes and the large (Klenow) fragment 
of DNA polymerase I were purchased from Boehringer Mannheim. 
The T4 DNA ligase and T4 polynucleotide kinase were obtained 
from Bethesda Research Laboratories. All antibiotics were 
from Sigma Chemical co. The [a-32P]dTTP, 3000 ~Cijmmol (1 
Ci = 37 GBq), was purchased from Amersham and the [y-32P]ATP 
was from ICN. 
DNA 
Oligonucleotides were synthesized by using the phosphor-
amidite chemistry (9) on the Applied Biosystems (Foster City, 
CA) DNA synthesizer, model 380A and purified by preparative 
polyacrylamide gel electrophoresis. 
Bacteriophage M13 mpB was grown in E. coli JM 103 (10) 
in 2 X YT medium. The DNA was prepared according to standard 
procedures (11). Plasmid pBR322 was grown in E. coli LS1 
(12) in LB medium (13) and prepared according to standard 
procedures (14). Numbering of the pBR322 is the one commonly 
used (13). 
DNA fragments were purified from 1.2% agarose gels 
using either DEAE-cellulose or an International Biotech-
nologies, Inc. (New Haven, CT) UEA electroelutor. 
Reactions 
Individual oligonucleotide strands were phosphorylated 
using standard procedures (13). 
Oligonucleotide strands were annealed by mixing 0.4 
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pmolel~l of each strand and heating to 95°C in 10 mM Mgcl 2 1 
50 mM Tris-HCl, pH 8, followed by gradual cooling to 20°c 
over a 45 minute period. 
For ligations, approximately 0.04 pmole of each restric-
tion fragment and 0.4 pmole of the synthetic fragment, were 
mixed in 10 mM MgCl2 I 50 mM Tris-HCl, pH 8 1 0.5 mM ATP 1 5 
mM dithiothreitol and 10 units of T4 DNA ligase and incubated 
at 15°C for 16 hours. The reaction mixture was extracted 
with phenol and the DNA was precipitated by addition of 
ethanol. The DNA was redissolved in 20 ~1 of 1 mM Tris-HCl, 
pH 8 I 0.1 mM EDTA; a 5 ~1 aliquot was used to transform 
competent E. coli LS1 cells. Cell transformations were done 
using standard procedures (15). 
Mutagenesis 
Oligonucleotide-directed mutagenesis was carried out on 
Ml3 mp8 containing the 752-base-pair Pst I to EcoRI fragment 
of pBR322. The following oligonucleotides were used: 
Ava I 5 1 -ACG TTC CTC GGG GCG 
Sea I 5 1 -ACA TAG CAG TAC TTT 
The procedures used for the mutagenesis (see Figure 1) are 
described elsewhere (16,17,18). To remove the preexisting 
Sea I site at 3846, the 61 base pair segment between Hincii 
at 3907 and Sea I at 3846 in pBR322 was removed and replaced 
with the following synthetic segment using the approach 
presented in Figure 2. 
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5 1 -GAC GCC GGG CAA GAG CAA CTC GGT CTC CGC ATA CAC TAT TCT-
CTG CGG CCC GTT CTC GTT GAG CCA GAG GCG TAT GTG ATA AGA-
CAG AAT GAC TTG GTT GAA T 
GTC TTA CTG AAC CAA CTT A-5 1 
To introduce the 20 amino acids at residue 71, the 
following mixture of oligonucleotides was ligated into the 
plasmid as shown in Figure 3. 
5 1 -CC GAG GAA CGT TTT CCA ATG ATG AGC~~~TT~ AAA 




The asterisk indicates a silent mutation that removes a 
Dra I site at 3943 and also decreases the self-complemen-
tarity of 6 (and possibly as many as 10} bases near this end 
of the individual strands. After ligation and transformation 
as described above, 1/10 of the cells from the transformation 
mixture were plated on tetracycline. Of the 423 resulting 
colonies, 105 were selected randomly and plasmids derived 
from these colonies were sequenced. 
DNA Sequencing 
The plasmids were digested with Ava I and the resulting 
2962 base pair fragments were isolated as described above. 
The fragment was labeled at nucleotide T-3973 using [a 
_32p]dTTP and the Klenow fragment of DNA polymerase I. 
This approach is shown in Figure 4. The labeled fragments 
were precipitated by addition of ethanol and pelleted by 
centrifugation; the pellet was washed with 70% ethanol and 
dried at reduced pressure. The labeled fragments were 
sequenced using standard techniques (19). The sequencing 
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gels were 40 em long and contained either 8% or 20% poly-
acrylamide (wtjvol) and 50% (wtjvol) urea and were run using 
standard procedures (13). 
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Results 
Restriction sites that could be introduced near residue 
71 without altering the amino acid sequence of B-lactamase 
were identified by reverse translating the amino acid 
sequence in this region of the protein and searching for 
restriction sites in the resulting degenerate sequence (see 
Figure 5). The Ava I and Sea I sites were closest to residue 
71 and occurred in only one other place in pBR322. Introduc-
tion of both sites require only single base changes. 
Introduction of the Ava I and Sea I sites and removal of 
the Sea I site at 3846 were verified by restriction mapping 
of the plasmids. The absence of other changes in the B-lac-
tamase gene was verified by sequencing one of the mutants 
from the Pst I site through the residues of the structural 
gene encoding the protein N terminus; this was the portion of 
the gene subcloned into Ml3 mp8 for the oligonucleotide-di-
rected mutagenesis. 
To determine whether the oligonucleotides were properly 
annealed by the procedure described in the Materials & Meth-
ods section, the annealed fragments were run on a nondenatur-
ing polyacrylamide gel (i.e., a polyacrylamide gel that 
contained no urea). One dark band was observed in the 
expected position; no other bands were observed. 
To optimize conditions for ligating the synthetic frag-
ment into the plasmid, several concentrations of synthetic 
fragment were used in normal ligation reactions and the 
resulting segments were analyzed by electrophoresis in 
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agarose gels. Concentrations of 4 pmole/50 ~1 substantially 
inhibited the reaction and 40 pmole/50 ~1 resulted in com-
plete inhibition; concentrations of 0.08 pmole/50 ~1 or less 
gave little or no ligation; 0.4 pmole/50 ~1 produced the 
maximum amount of ligation. Subsequently, all reactions were 
done using 0.4 pmole of the synthetic segment and 0.04 pmoles 
of plasmid fragments (less by a factor of 10 than the amount 
of synthetic segment) for a 50 ~1 reaction. I also tested 
reactions in which the 5'-end of the shorter oligonucle-
otide strand (the blunt end of the double stranded fragment) 
was either phosphorylated or non-phosphorylated; after 
ligation, no detectable difference was observed on agarose 
gels. Moreover, similar numbers of cells were obtained after 
transformations using DNA from either of these two reactions. 
After ligation of the mixture of oligonucleotides into 
the plasmid, transformation of competent E. coli LS1 cells 
gave 423 colonies that were resistant to tetracycline. 
Transformation of cells with plasmid from a parallel ligation 
in which the synthetic segment was omitted produced only four 
colonies indicating that only plasmids containing the syn-
thetic insert were able, after transformation, to confer 
tetracycline resistance. Plasmid DNA derived from 105 of the 
colonies (plasmid from 3 of the 108 original colonies did not 
label properly) was sequenced from Ava I (3972) through 
Sea I (3937). Table I lists the codon sequences for each of 
these 105 plasmids. Table II lists the codon frequencies in 
this collection of mutations. 
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Discussion 
The three fragment ligation shown in Figure 3 was 
designed to avoid two problems. First, an Ava I site occurs 
at nucleotide 1424 in pBR322 and, consequently, digestion of 
the plasmid in which the new Ava I site is present would 
result in cleavage at both the 1424 and 3972 Ava I sites; 
ligation of these fragments would result in undesirable 
plasmid constructions. Second, the method presented in 
Figure 3 will eliminate any background from wild type colon-
ies that could arise due to incomplete digestion at the Ava I 
or Sea I sites. Purifying the fragments shown in this figure 
completely eliminates the presence of the 35-base-pair seg-
ment between the Ava I and Sea I sites from the ligation 
reaction. Whereas transformation of competent cells with DNA 
from the ligation reaction shown in Figure 3 resulted in 423 
tetracycline resistant colonies, a parallel ligation in which 
the synthetic segment was omitted resulted in only 4 colonies 
indicating that only plasmids that had received the synthetic 
insert were able, after transformation, to confer tetracy-
cline resistance. These results indicate that this method is 
highly efficient for introducing the synthetic fragments 
without a significant background of wild .type plasmids. 
The Ava I site introduced at 3972 is a nonpalindromic 
recognition sequence. The use of nonpalindromic sequences is 
desirable since the four bases that protrude on the 5' end 
are not complementary to themselves; therefore, polymers of 
the synthetic sequence cannot form at this end of the segment 
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and these synthetic segments can ligate efficiently only to 
the fragment from pBR322 as desired. The blunt end arising 
from cleavage by Sea I is not optimal for ligating into the 
plasmid since blunt end ligations are not as efficient as 
ligations with complementary protruding ends. However, using 
the next potential restriction site in pBr322 near the region 
of interest would require an insert that is 25 bases longer 
than the segment required when using the Sea I site. Fortu-
nately, the results confirm that the efficienies of blunt end 
ligations are sufficient for our purposes. 
Importantly, for site saturation, one must generate 
all specified codons at nearly equal frequencies. If codons 
for certain amino acids are present at low frequencies, the 
corresponding mutants will be underrepresented, difficult to 
find, and may go untested in the experiment. Nearly equi-
molar mixtures of oligonucleotides can be obtained by careful 
synthesis (20,21) and then used in cassette mutagenesis to 
produce the various mutations at equal frequencies . 
In a Poisson distribution, the probability of finding a 
particular codon at least once among 101 colonies is 96% (4 
of the 105 clones that were sequenced contained single base 
insertions at the codon for residue 71 as discussed below). 
As shown in Table II, in the experiments described here 94% 
(30/32) of the codons were observed one or more times. The 
absence of two codons, therefore, was probably the conse-
quence of a small sample size. The probability of finding a 
codon between 2 and 4 times in a sample of 101 is predicted 
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to be 61%; in this experiment, 56% of the codons were 
observed between 2 and 4 times. 
Table III lists the observed frequencies of the individ-
ual bases at each position in the codon for residue 71. The 
C and G nucleotides occur somewhat less frequently than 
expected at the first position resulting in a slight skewing 
of the codon frequencies (see Table II). We observed a 
nearly equimolar mixture of bases at the other positions. 
Thus, the observed codon frequencies correlate well with the 
expected values; this demonstrates that under the conditions 
of the oligonucleotide synthesis, the four nucleoside phos-
phoramidites couple with almost equal efficiencies. Recently, 
the relative coupling efficiencies of phosphoramidite deri-
vatives of deoxynucleosides have been studied in detail (21) ; 
this study demonstrates that freshly dissolved methyl-N,N-
diisopropylamino phosphoramidite derivatives couple at nearly 
equivalent frequencies. However, two days after being dis-
solved, the guanosine derivative becomes significantly less 
reactive; this result stresses the importance of using fresh, 
pure reagents in the synthesis. 
In sequencing plasmids from 105 individual colonies, we 
found none in which the 35 base pair segment contained unex-
pected base substitutions. However, fourteen frameshift 
mutants resulting from single base deletions or additions 
were observed. Four mutants had one extra base (TGCC, GATC, 
CACC, CGGC) in the region corresponding to the codon for 
residue 71; one mutant had a single base addition within the 
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synthetic fragment not at residue 71; three mutants had 
single base deletions at the Sea I site; six mutants had 
single base additions and one a single base deletion near the 
Ava I site. The nine additions and deletions at restriction 
sites may occur during processing of the synthetic fragment 
or during ligation; similar deletions have been observed, for 
example, in ligation of a synthetic fragment into the Pst I 
site of the gene for subtilisin (8). The other five muta-
tions that occur within the synthetic fragment probably 
result from imperfections in the DNA synthesis. 
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Conclusion 
The approach described here will generate mutations that 
result in all possible amino acid substitutions in a protein 
at a residue of particular interest. This method was used to 
efficiently introduce 32 different codons at residue 71 in 
B-lactamase. The distribution of codons observed in 101 
colonies indicated that the various codons were introduced at 
equal frequencies. As an approach to studies of the rela-
tionships between structure and function in proteins, this 
method becomes particularly powerful for proteins that 
affect cell phenotype such that one can easily identify and 
select active mutants. One could then extend these studies 
to the saturation of multiple sites to assess the effect of 
combinations of residues on protein function. Presently, no 
other reported methods provide such an efficient and general 
technique for site saturation. Also, of the published meth-
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Table I - Cedens observed for plasmids in 108 colonies for site 
saturation of residue 71 in B-lactamase. 
Colony Amino Colony Amino Colony Amino 
Number Codon Acid Number Codon Acid Number Codon Acid 
1 TTG Leu 49 ATG Met 97 ATC Ile 
2 GTG Val 50 TCC Ser 98 GCG Ala 
3 AAC i * 51 TTG Leu 99 TAC Tyr 
4 CAC His 52 CAG d 100 AGG Arg 
5 TGC d* 53 AGG Arg 101 GGGC 
6 TCC Ser 54 GAC Asp 102 TAC Tyr 
7 GAG Glu 55 AGG Arg 103 ACC Thr 
8 TGCC 56 AAG Lys 104 AAG i 
9 GGG Gly 57 TGG Trp 105 TCG Ser 
10 TGC i 58 TAG stop 106 GGC Gly 
11 ACG Thr 59 TTG Leu 107 ? 
12 TTG Leu 60 TAC Tyr 108 ACC Thr 
13 ATC Ile 61 CAC His 
14 AAG Lys 62 CAC i 
15 CGG Arg 63 TCC Ser 
16 TAC Tyr 64 ACC Thr 
17 ATG Met 65 TGC Cys 
18 CCG Pro 66 AGC Ser * i or d indicates an 
19 GAG Glu 67 GCC Ala insertion or deletion 
20 ACG Thr 68 TTG Leu within the synthetic 
21 CCG Pro 69 ? fragment. 
22 GGC Gly 70 CAC i 
23 AAG Lys 71 TAC Tyr 
24 GCG Ala 72 TAC Tyr 
25 TGC Cys 73 TTG Leu 
26 CGG Arg 74 ATG Met 
27 TCC Ser 75 TGG i 
28 CTC Leu 76 AAG Lys 
29 GATC 77 AAC Asn 
30 CCC Pro 78 GCC Ala 
31 GCC Ala 79 GCG Ala 
32 TGG Trp 80 AAG Lys 
33 TGG Trp 81 CACC 
34 ATC Ile 82 TCG Ser 
35 ATC Ile 83 ATC Ile 
36 TTC Phe 84 TAC Tyr 
37 TAC Tyr 85 ATG Met 
38 TCC Ser 86 GCC Ala 
39 ATC Ile 87 ? 
40 TTG Leu 88 ATG Met 
41 GCG Ala 89 CTG i 
42 GAG Glu 90 AGC Ser 
43 ACC Thr 91 CTG d 
44 GAC Asp 92 TAG stop 
45 AGC Ser 93 ATG Met 
46 GCC Ala 94 TCG Ser 
47 ATG d 95 CAG Gln 
48 TGG Trp 96 AGG d 
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Table II - Frequencies of cedens observed at residue 71 
Number Number 
Codon Observed Codon Observed 
AAC 2 GAC 2 
AAG 6 GAG 3 
ACC 4 GCC 5 
ACG 2 GCG 4 
AGC 3 GGC 2 
AGG 4 GGG 1 
ATC 6 GTC 0 
ATG 7 GTG 2 
CAC 3 TAC 8 
CAG 3 TAG 2 
CCC 1 TCC 5 
CCG 2 TCG 3 
CGC 0 TGC 4 
CGG 2 TGG 5 
CTC 1 TTC 1 
CTG 2 TTG 6 
Insertion in degenerate codon 4 
Deletion at Sea I site 3 
Insertion at Ava I site 6 
Deletion at Ava I site 1 
Insertion in synthetic segment 1 
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Table III - Frequencies of bases at each position in the 
codon for residue 71. 
First Position Second Position Third Position 
Number Number Number 
Base Observed Base Observed Base Observed 
A 34 A 29 
c 14 c 26 c 47 
G 19 G 21 G 54 
T 34 T 25 
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CHAPTER II 
CHARACTERIZATION OF MUTANT B-LACTAMASES 
WITH ALL POSSIBLE AMINO ACID 
SUBSTITUTIONS AT RESIDUE 71 . 
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Introduction 
B-Lactamase catalyzes hydrolysis of the B-lactam ring of 
penam and cephem antibiotics (1) and thereby confers resis-
tance to these antibiotics on cells producing this enzyme. 
Several distinct B-lactamases have been isolated from a 
variety of bacteria; these enzymes have been classified into 
three groups: A, B, and C (2). The class A B-lactamases 
include the s. aureus PCl, B. licheniformis 749/c, B. cereus 
569/Hl as well as RTEM-1 and RTEM-2 enzymes. Many similar-
ities exist between the enzymes composing this class of 
B-lactamases, including sequence homologies, catalytic mecha-
nism, and probable three-dimensional structural similarities 
(2). Class B consists of a B. cereus enzyme that requires 
zinc for catalysis (3). Class C enzymes are the chromasomal 
B-lactamases from E. coli Kl2 and Ps. aeruginosa. The cata-
lytic mechanism of class C enzymes resembles that of class A 
enzymes in that a catalytic serine forms an acyl-enzyme 
intermediate; however, unlike the class A enzymes, these 
B-lactamases hydrolyze cephems more rapidly than penams (4,5) 
and also exhibit transferase activity toward added nucleo-
philes and will catalyze hydrolysis of the resulting esters 
(6). We have studied the RTEM-1 enzyme encoded on pBR322, 
which is a class A B-lactamase. 
The precise mechanism by which B-lactamases hydrolyze 
B-lactam antibiotics remains uncertain. The class A enzymes 
have been studied more thoroughly than class B or C enzymes; 
this discussion will address only class A enzymes. The ratio 
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of kcat to Km for good substrates such as benzylpenicillin 
approaches 108; the rate of catalysis for these good sub-
strates appears to be diffusion controlled (7). The first 
step in hydrolysis apparently involves formation of an acyl-
enzyme intermediate with an active site Ser (8,9) (Ser 70 in 
the consensus numbering for class A B-lactamases (10)) which 
can be observed directly for very poor substrates such as 
cefoxitin (11) or trapped at low pH or subzero temperatures 
for good substrates such as dansyl-penicillin (12). For 
cephalosporins, reclosure of the B-lactam ring and subsequent 
release of intact antibiotic from the enzyme occurs at 
approximately one third the rate of acylation (13) indicating 
that the conformation of the cephalosporinoyl group in the 
acyl-enzyme complex resembles that of free substrate; there-
fore, strain may exist in the acyl-enzyme bond. The rate of 
deacylation of the enzyme to produce the corresponding acid 
of the antibiotic is unaffected by the addition of external 
nucleophiles (11) suggesting the involvement of an as yet 
unidentified internal nucleophile. Although results such as 
these are adding quickly to our understanding of the cata-
lytic mechanisms of B-lactamase, the precise mechanism, as 
well as the specific amino acid residues (in addition to Ser 
70) involved in catalaysis, remain unclear. 
The class A B-lactamases contain a conserved triad 
(2) (Ser-Thr-x-Lys, residues 70 to 73 in the consensus num-
bering of these enzymes). The hydroxyl group of Ser 70 opens 
the B-lactam ring to form the acyl enzyme intermediate 
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(8,11). Replacement of this serine by Cys results in a 
mutant enzyme with reduced activity (14) whereas replacement 
by Thr results in an inactive enzyme (15); apparently, this 
position requires a primary nucleophile. The Lys at residue 
73 is conserved in all class A (2) and class C B-lactamases 
(16) as well as 0-Ala-D-Ala carboxypeptidases (17), which are 
the target enzymes for penam and cephem antibiotics and are 
likely to be related to the B-lactamases structurally (18), 
mechanistically, and possibly evolutionarily (19). My stud-
ies have focused on the conserved Thr 71, whose role in the 
ac1vity of B-lactamases was unknown. 
Using site saturation, I have generated all of the 
possible 19 amino acid substitutions at residue 71 (20) 
as described in Chapter I. Analysis of these mutant enzymes 
included determination of their ability to confer in vivo 
resistance to penam and cephem antibiotics and determination 
of the relative quantities of enzyme in whole cell extracts 
of E. coli by antibody stains of electrophoretic blots. 
Surprisingly, cells containing any of 14 of the mutant B-
lactamases displayed appreciable resistance to ampicillin, 
only cells containing mutants with Tyr, Trp, Asp, Lys, or Arg 
at residue 71 had no observable resistance to ampicillin. 
However, all of the 19 mutant proteins show significantly 
increased sensitivity to proteolysis, especially at 37°C. 
These results suggest that this residue is not directly 
involved in binding or catalysis but is important for sta-
bility of the protein. 
Cells 
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Materials & Methods 
E. coli LS-1 cells (21) containing wild type or mutant 
B-lactamase genes on pBR322 as described in Chapter I were 
grown in LB media (22) (L-broth and L-agar) containg 15 mg/1 
of tetracycline or the stated concentration of penam or 
cephem antibiotics. 
Phenotype screens 
Initially, resistance to penam or cephem antibiotics was 
determined by using sterile toothpicks to pick individual 
colonies and then to innoculate specific positions on an agar 
plate containing an appropriate concentration of antibiotic. 
More accurate values for the maximal level of antibiotic 
resistance provided to cells for the various mutants were 
determined by spreading cells onto L-agar plates containing a 
continuous concentration gradient of antibiotic. Antibiotic 
concentration gradients were generated by elevating one end 
of a petri dish 5 mm and pouring 15 ml of L-agar containing 
an appropriate concentration of antibiotic into the tilted 
dish. These were allowed to dry overnight. The plates were 
then placed on a flat, horizontal surface and 15 ml of L-agar 
was poured on top; the plates were used immediately after 
they hardened. A 50 ~1 aliquot of a 1:105 dilution of a 
saturated culture (a saturated culture of E. coli LS1 con-
tains approximately 2 X 109 cells per ml) was spread over 
half of the plate. A standard mutant was plated on the other 
half; standards used were as follows: for ampicillin and 
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benzylpenicillin at 37°C and for 6-aminopenicillanic acid at 
30°C, Thr 71 --> Leu; for 6-aminopenicllanic acid at 37oc, 
Thr 71 --> Cys; for ampicillin and benzylpenicillin at 30°C, 
Thr 71 --> Glu. These standards were used because colonies 
containing these mutants grew up to approximately half of the 
maximal concentration of antibiotic in the plates under the 
conditions described above. 
Protein gels and electrophoretic blots 
Whole cell extracts were prepared for E. coli harboring 
plasmids encoding either mutant or wild type B-lactamases. 
The cells were grown to late log-phase (O.D. at 600 nm - 1) 
and the absorbance at 600 nm was measured. The cells were 
pelleted by centrifugation and resuspended in loading buffer 
[10% (voljvol ) glycerol I 5% (voljvol) 2-mercaptoethanol 1 
3% (wtjvol) sodium dodecyl sulfate/ 62.5 mM Tris-HCl, pH 6.8 
I 1.0 mM EDTA] and incubated 10 minutes at 95°C. Cells from 
cultures with densities of 1 o.o. were resuspended in 100 ~1 
of loading buffer; cells from cultures with slightly higher 
or lower densities were resuspended in proportionally 
greater or lesser volumes of loading buffer. 20 ~1 ali-
quots of these whole cell extracts were loaded onto a 15 em 
12% polyacrylamide gel with a 2 em 4% stacking gel and 
electrophoresed at 5 mA for approximately 12 hours. 
The protein was transferred from the polyacrylamide 
gel to nitrocellulose by electrophoresis (electrophoretic 
blot or western blot) according to the Bio-Rad procedure 
(23): the polyacrylamide gel was washed for 30 minutes in 25 
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mM Tris base I 192 mM glycine (pH - 8.3) I 20% (vollvol) 
methanol; the gel was then sandwiched between blotting paper 
and pure nitrocellulose (Schleicher & Scheull) and electro-
phoresed in a Bio-Rad Trans-Blot cell at 50 V for 5 hours. 
The nitrocellulose was stained according to the proce-
dure from the Vectastain ABC kit (24) using antibody raised 
against B-lactamase in rabbits. The initial injection used 
to raise antibody contained denatured B-lactamase purified by 
SDSipolyacrylamide gel electrophoresis (25); booster shots 
contained protein purified as described elsewhere (25). The 
rabbit was bled after the booster shot and serum was col-
lected and used without furthur purification. However, the 
membrane was first treated with a solution of 1% (wtlvol) BSA 
and 0.1% (vollvol) normal goat serum for 1.5 hours at room 
temperature. For binding of the primary antibody, a 1:1000 
dilution of rabbit antiserum in TPBS was incubated with the 
nitrocellulose membrane for 1 hour at room temperature. 
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Results 
From the 423 colonies obtained after tranformation 
of cells with DNA from ligation of the synthetic insert 
into the plasmid as described in Chapter I, 108 colonies 
were picked onto L-agar plates containing tetracycline and 
were also tested for resistance to ampicillin (10, 50, 100, 
and 500 mg/1), benzylpenicillin (100 mg/1), 6-aminopenicil-
lanic acid (10, 25, 50, and 100 mg/1), cephalothin (25, 50, 
and 100 mg/1), and cephalexin (25 and 50 mg/1). Ampicillin 
and cephalothin plates were incubated at 30°C and 37°C; all 
others were incubated only at 37°C. The results are pre-
sented in Table I. This phenotype screening indicated that a 
change in antibiotic specificity and reduced stability parti-
cularly at 37°C were characteristics of some of the mutants. 
After sequencing plasmids derived from 105 of these 
colonies as discussed in Chapter I, the sequences were 
matched to the phenotypes determined above (see Table I). 
Mutants with Tyr, Trp, Asp, Lys, and Arg at position 71 gave 
no resistance to any of the five antibiotics. A mutant with 
Phe was resistant to 100 mgjl of ampicillin at 30°C, but 
sensitive even to low levels of ampicillin at 37°C. Mutants 
with Gly, Gln, and Glu produced resistance up to 100 mg/1 of 
ampicillin and benzylpenicillin at 37°C. Mutants with Ala, 
Val, Leu, Ile, Pro, His, Cys, Ser, Thr, and Asn gave resis-
tance to >500 mg/1 of ampicillin and >100 mg/1 of benzylpeni-
cillin. Only mutants with His, Cys, Ser, and Thr were resis-
tant to >100 mgjl of 6-arninopenicillanic acid, those with 
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Gly, Ala, Val, Leu, Ile, Pro, Glu, Gln, and Asn were resis-
tant to 25 mg/1, and those with Met (although resistant to 
ampicillin) showed no resistance to 6-aminopenicillanic 
acid. Only the wild type enzyme (Thr 71) was resistant to 
cephalothin and cephalexin at 37°C. Mutants with Ser at 
residue 71 were resistant to 50 mg/1 of cephalothin at Jooc, 
but none of the other mutants grew in the presence of this 
antibiotic. 
More accurate values for the level of antibiotic resis-
tance provided to cells by the mutant proteins were deter-
mined by spreading cells onto an agar plate with a continuous 
concentration gradient of antibiotic. The maximal concentra-
tion at which colonies were established could then be 
observed; these values are presented in Table II. These 
values were independent of dilutions of cells higher by a 
factor of 2 or lower by a factor of 5 than the dilutions used 
in determining the phenotypic characteristics. 
Whole cell extracts from approximately 1 X 108 E. coli 
cells harboring the various wild type and mutant plasmids 
incubated either at 30°C or 37°C were electrophoresed in 
denaturing sodium dodecyl sulfate 1 polyacrylamide gels and 
then transferred to nitrocellulose. Figure 1 shows antibody 
stains of these blots. B-Lactamase or its mutants are pres-
ent in all lanes, but the quantity varies substantially 
for different mutants; this variation is greatly reduced at 
Jooc. We believe that the protein responsible for the band 
slightly above B-lactamase is pre-B-lactamase because it 
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represents a protein of the appropriate size and because this 
band is absent for the Thr 71 --> amber mutant. The blots 
suggest that the mutant proteins are processed normally, but 
that mature mutant proteins are more susceptible than wild-
type B-lactamase to degradation, probably by periplasmic 
proteases. Some of the bands below those for intact mutants 
of B-lactamase likely represent proteolytic fragments and 
appear to differ slightly between the various mutants. 
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Discussion 
The antibiotic resistances of colonies containing the 19 
mutant B-lactamases were initially determined by picking 
colonies onto agar plates with various levels of antibiotics 
(see Table I). More accurate values were measured by plating 
cells containing the mutants onto agar plates having a linear 
concentration gradient of antibiotics (see Table II). This 
latter method gives consistently lower values for antibiotic 
resistance as in this case individual cells must establish 
colonies whereas when picking colonies many cells are ini-
tially present at a single site, allowing them to cooperate 
in inactivating sufficient antibiotic to allow growth (this 
is commonly called the innoculum effect). However, both 
sets of data are useful as colonies with mutants having 
low lactamase activity would be classified as inactive if 
only plating were used. In Table II, colonies that grew when 
picked, but not when plated, are designated as having trace 
activity. 
The antibiotic resistance of colonies containing mutant 
plasmids reflects many factors: plasmid copy number, rate of 
transcription, stability and rate of translation of the 
mutant mRNAs, stability of pre-B-lactamase in the cytoplasm, 
rate of processing and secretion, stability of the protein in 
the periplasm, and, finally, the intrinsic enzymatic 
activity. 
With regard to the steps from transcription through 
translation, the codon used for a given amino acid at residue 
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71 did not alter observed antibiotic resistance. For 
example, wild type enzyme with ACT (pBR322), ACC or ACG for 
Thr 71 all confer the same level of antibiotic resistance as 
do Thr 71 --> Ser mutants with TCC, AGC, TCG, or TCT for 
serine and Thr 71 --> Leu mutants with TTG or TTC for leu-
cine. Likewise, for all of the active mutants listed in 
Table II, different codons for the same amino acid always 
produced identical values for the maximal level of antibiotic 
resistance. Though the presence of infrequently used codons 
in E. coli may affect translation (26), our results do not 
implicate this as the dominant factor in the observed pheno-
typic resistances for the conditions used in these experi-
ments. 
Mutations may affect processing and secretion of pro-
teins (27) and thereby alter the relative concentrations 
of mutant B-lactamases in the periplasm. Although mutants 
such as Thr 71 --> Ser and Ser 70 --> Thr and the double 
mutant Ser 70 --> Thr, Thr 71 --> Ser are processed and 
secreted normally in Salmonella typhimurium (25), these 
mutations are unlikely to affect these processes as dras-
tically as mutations such as Thr 71 --> Trp, Tyr, Lys; even 
in these cases, however, abundant processed protein is appa-
rent in cells growing at 30°C (see Figure 1). 
Resistance to thermal denaturation and proteolysis 
can greatly influence the in vivo concentration of mutant 
proteins (25,28). Antibody stains of electrophoretic blots 
for whole cell extracts of E. coli harboring the wild type or 
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mutant plasmids grown at 30°C and 37°C show significant 
differences in the in vivo concentrations of the various 
mutants. A band representing the precursor protein shows 
similar intensities for the mutant and wild type enzymes; the 
presence of normal amounts of precursor proteins suggests 
that processing and secretion have not been drastically 
altered for the mutants. However, the amounts of protein in 
the periplasm vary greatly for the mutants as contrasted to 
wild type, particularly for cells growing at 37°C. The 
electrophoretic blots were carried out on samples after 
denaturation, boiling with 2-mercaptoethanol and elecrophor-
esis with SDS; consequently, the reduced amounts of mutant 
proteins relative to wild type B-lactamase result from more 
extensive proteolysis rather than simple thermal denaturation 
of the mutants. 
In these blots, the relative antigenicities of the 
various denatured B-lactamases could significantly affect the 
amounts of mutant proteins apparently present. The proteins 
in question have been denatured, the antibody is polyclonal 
rabbit antiserum raised against denatured wild type B-lactam-
ase and the mutants in question have only single site sub-
stitutions; for these reasons, the relative antigenicities 
of the mutants should not differ appreciably from each other 
or from that of the wild type protein. The relatively cons-
tant amount of an unidentified E. coli protein in all lanes 
serves as an internal standard to ensure that nearly similar 
amounts of total protein were loaded onto each of the lanes. 
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Accordingly, the relative intensities of the bands for wild 
type and mutant B-lactamases should reflect the relative 
amounts of these mutants actually present under the condi-
tions specified. 
A surprising number of mutants with amino acid substitu-
tions at residue 71 display lactamase activity; indeed, of 
the 19 substitutions at residue 71 only 5 (Trp, Tyr, Lys, 
Arg, and Asp) give proteins that confer no observable resis-
tance to ampicillin or benzylpenicillin. Enzymes with Gln, 
Glu, Asn, and Phe at residue 71 provide low level resistance, 
but enzymes with all other amino acids at this site have high 
activity toward benzylpenicillin and ampicillin. 
Some conclusions about structure-function relationships 
can be drawn from these data. Mutants having amino acids 
with charged or very large side cains at residue 71 have at , 
best very low activity, otherwise both polar and non-polar 
side chains seem compatible with appreciable activity . When 
6-aminopenicillanic acid is used to select for activity, 
mutants with amino acids having non-polar side chains at 
residue 71 show decreased acivity whereas mutants with amino 
acids having polar side chains at residue 71 retain high 
levels of activity toward this antibiotic. All mutants 
show a dramatically decreased ability to confer resistance 
toward the cephem antibiotics cephalothin and cephalexin. At 
3ooc, wild type B-lactamase (Thr 71) confers resistance to at 
least 100 mgjl of cephalothin while the mutant Thr 71 --> Ser 
confers resistance only to low levels of the cephem antibi-
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otics; at 37°C only wild type enzyme provides observable 
resistance. 
Because many mutants at residue 71, including those 
having amino acids with polar and non-polar side chains 
at this residue, show appreciable activity toward penams, we 
conclude that Thr at residue 71 is not essential for binding 
or catalysis, though it may perform some contributing role in 
these functions. However, residue 71 does play a very impor-
tant role in the structural stability of the protein as 
observed in the increased sensitivity to proteolysis of all 
19 mutants. The importance of branching at the B-carbon of 
threonine with a polar hydroxyl group and non-polar methyl 
group is demonstrated, for example, by the increasing antibi-
otic resistance of cells growing at 37°C provided by the 
series of enzymes with Gly < Ala < Leu < Val at residue 
71. The increased thermal and proteolytic sensitivity (rela-
tive to wild type) of the mutant Thr 71 --> Ser (25), lacking 
only the methyl group of Thr, further supports this view. 
Interestingly, in a recent study of proteins from mesophilic 
and thermophilic bacteria, Ser --> Thr substitutions were 
frequently observed (29) suggesting that Thr can provide 
greater thermal stability to proteins than Ser. The high 
levels of catalytic activity observed for the Thr 71 --> Cys 
and Thr 71 --> Ser mutants demonstrate the importance of the 
polar group. The reduced activity toward 6-aminopenicillanic 
acid of enzymes having amino acids with non-polar side chains 
at residue 71 suggests that the side chain of residue 71 
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influences the hydrophobic or hydrophilic characteristics 
(possibly hydration) of the pocket that accommodates the 
substituent attached to the S-lactam ring of the substrate. 
This possibility is further emphasized by the lower activity 
of enzymes with Glu and Gln at residue 71 toward benzylpeni-
cillin (neutral, non-polar substituent) than toward ampicil-
lin (positively charged substituent). 
The high level of activity observed for the Thr 71 
--> Ile and Thr 71 --> His mutants was surprising; one would 
not consider these amino acids as suitable replacements for 
Thr. The Thr 71 --> Ile mutant appears to be slightly more 
stable than mutants with other nonpolar amino acid side 
chains at residue 71, perhaps emphasizing the importance of a 
nonpolar interaction in this region of the protein as with 
the methyl group of threonine. The high level of activity 
observed for the Thr 71 --> His mutant is difficult to inter-
pret; possibly the hydrogen bonding abilities of the side 
chain of this residue resemble those of threonine. The 
stability of the Thr 71 --> Pro mutant as seen in Figure 
2 is also noteworthy. The proline side chain may reduce 
the conformational flexibilty at residue 71; however, the 
stability of this mutant protein remains well below that of 
the wild type enzyme. 
All mutants confer on cells at best very low resistance 
toward cephalothin and cephalexin; this likely results from 
the inherently lower activity of S-lactamase against cephem 
antibiotics (30) and accords with results observed for muta-
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tions in other regions of the enzyme (31). This behavior 
also demonstrates the importance of the conserved residues at 
the catalytic site in providing an enzyme with high levels of 
catalytic activity and stability. 
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Conclusion 
I have used the site-saturation approach to structure-
function studies of proteins to determine the role of Thr 71 
in the activity of the pBR322 encoded RTEM-1 B-lactamase. 
The results demonstrate that residue 71 has little or no 
affect on binding or catalysis but is essential for stability 
of the protein. One would not have predicted that Thr could 
perform such a unique structural role; even Ser does not 
adequately replace Thr at this site in the protein. The 
results also indicate that residue 71 may influence the 
region of the protein that accommodates the side chain 
attached to the B-lactam ring of the substrate. Particu-
larly surprising results were obtained for the Thr 71 --> Ile 
and Thr 71 --> His mutants; one would not have predicted that 
these residues could adequately replace Thr. 
The results presented here demonstrate the potential of 
site saturation for determining the role of specific amino 
acid residues in the function of a protein. Future studies 
using site saturation should produce many new insights into 
the relationships between structure and function in proteins. 
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Figure II-1. Electrophoretic blots of B-lactamases with the 
19 amino acid substitutions at residue 71. The blots were 
treated with anti-B-lactamase antibody and visualized using 
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Table I. - Maximal level of resistance determined by picking. 
BenzylJ2en. Am}2icillin Amino12en. CeJ2halothin 
3o£g 37£g 3o£g 37Qg 
1. TTG Leu >100 >500 100 25 0 0 
2. GTG Val >100 >500 >500 50 0 0 
3. AAC i* 0 0 0 0 0 0 
4. CAC His >100 >500 >500 >100 0 0 
5. TGC d* 0 0 0 0 0 0 
6. TCC Ser >100 >500 >500 >100 0 0 
7. GAG Glu 0 100 50 0 0 0 
8. TGCC 0 0 0 0 0 0 
9. GGG Gly >100 >500 100 25 0 0 
10. TGC i 0 0 0 0 0 0 
11. ACG Thr >100 >500 >500 >100 >100 >100 
12. TTG Leu >100 >500 >500 25 0 0 
13. ATC Ile >100 >500 >500 25 0 0 
14. AAG Lys 0 0 0 0 0 0 
15. CGG Arg 0 0 0 0 0 0 
16. TAC Tyr 0 0 0 0 0 0 
17. ATG Met >100 >500 >500 50 0 0 
18. CCG Pro >100 >500 >500 25 0 0 
19. GAG Glu 0 >500 100 25 0 0 
20. ACG Thr >100 >500 >500 >100 >100 >100 
21. CCG Pro >100 >500 >500 25 0 0 
22. GGC Gly >100 >500 100 25 0 0 
23. AAG Lys 0 0 0 0 0 0 
24. GCG Ala >100 >500 >500 25 0 0 
25. TGC Cys >100 >500 >500 >100 0 0 
26. CGG Arg 0 0 0 0 0 0 
27. TCC Ser >100 >500 >500 >100 50 0 
28. CTC Leu >100 >500 >500 25 0 0 
29. GATC 0 0 0 0 0 0 
30. CCC Pro >100 >500 >500 >100 0 0 
31. GCC Ala >100 >500 >500 25 0 0 
32. TGG Trp 0 0 0 0 0 0 
33. TGG Trp 0 0 0 0 0 0 
34. ATC Ile >100 >500 >500 25 0 0 
35. ATC Ile >100 >500 >500 25 0 0 
36. TTC Phe 0 100 10 0 0 0 
37. TAC Tyr 0 0 0 0 0 0 
38. TCC Ser >100 >500 >500 >100 25 0 
39. ATC Ile >100 >500 >500 >100 0 0 
40. TTG Leu >100 >500 >500 25 0 0 
41. GCG Ala >100 >500 >500 25 0 0 
42. GAG Glu 0 >500 >500 0 0 0 
43. ACC Thr >100 >500 >500 >100 >100 >100 
44. GAC Asp 0 0 0 0 0 0 
45. AGC Ser >100 >500 >500 >100 50 0 
46. GCC Ala >100 >500 >500 25 0 0 
47. ATG d 0 0 0 0 0 0 
48. TGG Trp 0 0 0 0 0 0 
49. ATG Met >100 >500 >500 0 0 0 
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Table I. (continued) 
Benzyl}2en. Am}2icillin Amino12en. Ce}2halothin 
302g 372.Q 3o2g 372g 
50. TCC Ser >100 >500 >500 >100 50 0 
51. TTG Leu >100 >500 >500 >100 0 0 
52. CAG d 0 0 0 0 0 0 
53. AGG Arg 0 0 0 0 0 0 
54. GAC Asp 0 50 0 0 0 0 
55. AGG Arg 0 0 0 0 0 0 
56. AAG Lys 0 0 0 0 0 0 
57. TGG Trp 0 0 0 0 0 0 
58. TAG stop 0 0 0 0 0 0 
59. TTG Leu >100 >500 >500 25 0 0 
60. TAC Tyr 0 0 0 0 0 0 
61. CAC His >100 >500 >500 >100 0 0 
62. CAC i 0 0 0 0 0 0 
63. TCC Ser >100 >500 >500 >100 50 25 
64. ACC Thr >100 >500 >500 >100 >100 >100 
65. TGC Cys >100 >500 >500 >100 0 0 
66. AGC Ser >100 >500 >500 >100 0 0 
67. GCC Ala >100 >500 >500 10 0 0 
68. TTG Leu >100 >500 >500 >100 0 0 
69. ? Thr (?) >100 >500 >500 >100 >100 >100 
70. CAC i 0 50 0 0 0 0 
71. TAC Tyr 0 0 0 0 0 0 
72. TAC Tyr 0 0 0 0 0 0 
73. TTG Leu >100 >500 >500 25 0 0 
74. ATG Met >100 >500 >500 25 0 0 
75. TGG i 0 0 0 0 0 0 
76. AAG Lys 0 0 0 0 0 0 
77. AAC Asn >100 >500 >500 25 0 0 
78. GCC Ala >100 >500 >500 25 0 0 
79. GCG Ala >100 >500 >500 25 0 0 
80. AAG Lys 0 0 0 0 0 0 
81. CACC 0 0 0 0 0 0 
82. TCG Ser >100 >500 >500 >100 50 0 
83. ATC Ile >100 >500 >500 25 0 0 
84. TAC Tyr 0 0 0 0 0 0 
85. ATG Met >100 >500 >500 25 0 0 
86. GCC Ala >100 >500 >500 25 0 0 
87. ? Thr (?) >100 >500 >500 >100 >100 >100 
88. ATG Met >100 >500 >500 25 0 0 
89. CTG i 0 0 0 0 0 0 
90. AGC Ser >100 >500 >500 >100 50 25 
91. CTG d 0 0 0 0 0 0 
92. TAG stop 0 0 0 0 0 0 
93. ATG Met >100 >500 >500 25 0 0 
94. TCG Ser >100 >500 >500 >100 50 0 
95 . CAG Gln >100 >500 50 0 0 0 
96. AGG d 0 0 0 0 0 0 
97. ATC Ile >100 >500 >500 >100 0 0 
98. GCG Ala >100 >500 >500 25 0 0 
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Table I - (continued) 
Benzy:l:gen . AmJ2icillin AminoJ2en. Ce:ghalothin 
3oQg 37Qg d_Q_Qg 37Qg 
99. TAC Tyr 0 0 0 0 0 0 
100. AGG Arg 0 0 0 0 0 0 
101. GGGC 0 0 0 0 0 0 
102 . TAC Tyr 0 50 0 0 0 0 
103. ACC Thr >100 >500 >500 >100 >100 >100 
104 . AAG i 0 0 0 0 0 0 
105 . TCG Ser >100 >500 >500 >100 50 0 
106. GGC Gly >100 >500 100 25 0 0 
107. ? >100 >500 >500 >100 0 0 
108 . ACC Thr >100 >500 >500 >100 >100 >100 
*i=insertion, d=deletion in the synthetic fragment. 
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Table II - Maximal level of resistance of cells containing residue 71 




Acid Cedens Ampicillin Benzylpenicillin Acid 
l.QQ_Q 37Q_Q 30Q_Q 37Q_Q 30Q_Q 37Q_Q 
Gly GGC, GGG >500 trace >500 50 35 20 
Ala GCG, GCC >500 75 >500 100 trace trace 
Val GTG >500 150 >500 175 75 trace 
Leu TTG, CTC, CTG >500 100 >500 125 80 trace 
Ile ATC >500 >500 >500 >500 90 40 
Met ATG >500 125 >500 150 30 0 
Pro CCG, CCC >500 200 >500 350 50 40 
Phe TTC 60 0 0 0 0 0 
Trp TGG 0 0 0 0 0 0 
Tyr TAC 0 0 0 0 0 0 
His CAC >500 >500 >500 >500 >250 >250 
Cys TGC >500 >500 >500 >500 >250 100 
Ser TCC, AGC, TCG >500 >500 >500 >500 >250 >250 
Thr ACG, ACC >500 >500 >500 >500 >250 >250 
Asn AAC 270 trace 210 trace 55 trace 
Gln CAG 130 20 70 trace trace 0 
Asp GAC 0 0 0 0 0 0 
Glu GAG 200 trace 70 trace trace trace 
Lys AAG 0 0 0 0 0 0 
Arg CGC, AGG 0 0 0 0 0 0 
Stop TAG 0 0 0 0 0 0 
>A indicates that this value was the highest level of antibiotic tested 
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CHAPTER III 
ROLE OF A DISULFIDE BOND IN STABILIZING 
RESIDUE 71 MUTANTS OF B-LACTAMASE 
66 
Introduction 
Disulfide bonds in proteins can perform a variety of 
functions such as regulation of the activity of eukaryotic 
proteins (1), maintainance of the structural integrity of 
processed proteins (such as insulin) (2), and stabilization 
of the native conformation of globular proteins (3,4). 
Whereas stabilization of the native conformation of globular 
proteins has been the subject of numerous studies, the pre-
cise mechanisms by which disulfide bonds can participate 
in the dynamics of folding and unfolding and, therefore, 
protein stability remain uncertain. Several studies indicate 
that proteins with naturally occuring disulfide bonds can 
assume their native conformation without formation of disul-
fide bonds (5,6) and can retain their normal activity after 
reduction of the disulfide bonds (7). These results suggest 
that disulfide bonds that provide conformational stability 
generally do not dictate folding and may not affect catalytic 
activity. 
Of the known class A B-lactamases (8) (EC 3.5.2.6), 
only the RTEM-1 and RTEM-2 B-lactamases encoded by plasmids 
pBR322 and R6K respectively, contain a disulfide bond (9,10); 
this bond is between residues 77 and 123 according to the 
numbering of the consensus sequence (8). Complete reduction 
of this disulfide bond requires harsh conditions that irre-
versibly denature the protein; consequently, studies compar-
ing activities of the protein with and without the disulfide 
bond have not been feasible. 
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Modern techniques for site-specific mutagenesis (11,12) 
permit one to remove disulfide bonds without chemically 
reducing the protein. The naturally occurring disulfide 
bonds were removed from interleukin-2 by replacing cysteine 
residues with either serine (13) or alanine (14); although 
the mutant proteins were active, these activities were sub-
stantially lower than that of the wild type protein. Site-
specific mutagenesis also allows the introduction of disul-
fide bonds into proteins; disulfide bonds have been success-
fully introduced into dihydrofolate reductase (15) and T4 
lysozyme (16,17). Such experiments require high resolution 
three-dimensional structures to identify potential sites that 
will allow formation of a disulfide bond while minimizing 
undesirable effects on the conformation or activity of the 
protein. 
I have introduced a mutation into the B-lactamase gene 
on pBR322 that changes Cys 77 to Ser. The wild type and 
mutant enzymes confer the same high levels of in vivo resis-
tance to ampicillin. The activities of purified mutant 
and wild type enzymes are indistiguishable at 30°C using 
benzylpenicillin as the substrate at pH values between 5 and 
8 (Neitzel, J.J. & Richards, J.H., unpublished results). 
However, the thermal stability of the purified mutant enzyme 
is reduced at elevated temperatures (above 40°C). The mutant 
enzyme is also less active than the wild type enzyme in 
alkaline solutions (above pH 8) (Neitzel, J.J. & Richards, 
J.H., unpublished results). These results indicate that the 
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Cys 77 --> Ser mutation affects the activity and conforma-
tional stability of the B-lactamase protein only when exposed 
to harsh environments. 
In the previous chapters, I discussed the production and 
characterization of mutant RTEM-1 (pBR322) B-lactamases with 
all possible amino acid substitutions at residue 71 (18). 
All of these mutations resulted in proteins with dramatically 
decreased stability to E. coli proteases at 37°C; however, at 
30°C we observed stabilities similar to the wild type 
enzyme. Fourteen of the mutations exhibited high levels of 
activity on ampicillin and benzylpenicillin, including the 
Thr 71 --> Ile mutant (18). However, the mutation corre-
sponding to Thr 71 --> Ile in the s. aureus PC1 B-lactamase 
(also a class A B-lactamase) results in an inactive enzyme 
(8), probably due to incomplete folding (19). The disulfide 
bond, which is present in the RTEM-1 enzyme but not in the 
s. aureus PC1 enzyme may contribute to this difference 
between these homologous enzymes, perhaps by stabilizing the 
catalytically active conformation. 
To study the role of the disulfide bond in stabilizing 
B-lactamases with mutations at residue 71, I introduced the 
Cys 77 --> Ser mutation into all 19 of these mutants. I 
analyzed these 19 doubly mutant proteins for their ability to 
confer resistance to ampicillin in vivo and used electrophor-
etic blots stained with antibodies against B-lactamase to 
estimate the relative quantities of the mutant enzymes in 
whole cell extracts from E. coli .• The results indicate that 
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although several of the doubly mutant enzymes retain cataly-
tic activity (including the Thr 71 --> Ile, Cys 77 --> Ser 
mutant), these mutants are much less stable than the anala-
gous single mutants that contain a disulfide bond. Appar-
ently, the presence of the disulfide bond in B-lactamase 
enables the protein to partially overcome instabilities 
arising from mutations at residue 71. The results presented 
here also demonstrate that Thr at residue 71 performs a 
unique and essential role in the structure and stability of 
B-lactamase. 
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Materials & Methods 
Enzymes and Chemicals 
Restriction enzymes and the large (Klenow) fragment 
of DNA polymerase I were purchased from Boehringer Mannheim. 
T4 DNA ligase and T4 polynucleotide kinase were obtained from 
Bethesda Research Laboratories. All antibiotics were from 
Sigma. [a-32p]dTTP, 3000 ~Cilmmole (1 Ci = 37 GBq), was 
purchased from Amersham. 
DNA 
Oligonucleotides were synthesized by using the phosphor-
amidite chemistry {20) on the Applied Biosystems {Foster 
City, CA) DNA synthesizer, model 380A and purified by prepar-
ative polyacrylamide gel electrophoresis. 
Plasmid DNA was prepared from E. coli LSl (21) cultured 
in LB medium (22) using standard procedures (23) . DNA frag-
ments were purified from 1.2% agarose gels using the Interna-
tional Biotechnologies, Inc. UEA electroelutor. Numbering of 
pBR322 nucleotides is the one commonly used (22). 
Reactions 
Individual oligonucleotide strands were phosphorylated 
using standard procedures (22). The oligonucleotides were 
annealed by mixing 0.4 pmole/~1 of each strand and heating to 
95°C in 10 mM MgC12 1 50 mM Tris-HCl, pH 8, followed by 
gradual cooling to 20°c over a 45 minute period. 
For ligations, approximately 0.04 pmole of each restric-
tion fragment and 0.4 pmole of the synthetic fragment, where 
appropriate, were mixed in 10 mM MgCl2 I 50 mM Tris-HCl, pH 8 
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I 0.5 mM ATP I 5 mM dithiothreitol and 5 units of T4 DNA 
ligase and incubated at 15°C for 16 hours. The reaction 
mixture was extracted with phenol and the DNA was precipita-
ted by addition of ethanol. The DNA was redissolved in 20 ~1 
of 1 mM Tris-HCl, pH 8 I 0.1 mM EDTA; an aliquot (5~1) was 
used to transform competent E. coli LS1. Cell transforma-
tions were done using standard procedures (24). 
Mutagenesis 
I introduced the Cys 77 --> Ser mutation into the B-lac-
tamase gene by cloning the following synthetic oligonucleo-
tide segment into the Sea I and Hincii sites in the B-lacta-
mase gene (see Figure 1). 
** * 5 1 - A-CTG-CTA-TCA-GGC-GCC-GTA-TTA-TCC-CGT-GTT 
T-GAC-GAT-AGT-CCG-CGG-CAT-AAT-AGG-GCA-CAA 
After ligation and transformation, cells were grown in the 
presence of ampicillin (200 mgll). 
I combined the Cys 77 --> Ser mutation with the 19 
mutations at residue 71 by combining the 2568 b.p. sty I 
to Sea I fragment from plasmid pBR322-DCS4 with the 1793 
b.p. Sea I to Sty I fragment from the appropriate residue 71 
mutant (see Figure 2). After ligation and transformation, 
cells were grown in the presence of tetracycline (15 mgll). 
DNA Sequencing 
The plasmids were digested with Ava I and the resulting 
2962 b.p. fragments were isolated as previously described. 
The fragment was labeled at nucleotide 3973 using [a-32P]dTTP 
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and the Klenow fragment of DNA polymerase I. The labeled 
fragments were sequenced by using standard techniques (25}. 
Antibiotic Concentration Gradients 
An antibiotic concentration gradient was generated 
in L agar plates by elevating one end of a Petri dish (8.5 em 
diameter} 5 mm and pouring 15 ml of L agar (22} containing an 
appropriate concentration of antibiotic into the tilted 
dish. These were allowed to dry overnight. The plates were 
then placed on a flat horizontal surface and 15 ml of L agar 
was poured on top; they were used immediately upon harden-
ing. An aliquot (50 ~1) of a 1:105 dilution of a saturated 
culture (approximately 2 x 109 cells per ml for a saturated 
culture of E. coli LSl) was spread over half of the plate; 
the Thr 71 --> Gln mutant (18) was plated on the other half 
as a standard. 
Protein Gels and Electrophoretic Blots 
Whole cell extracts were prepared for E. coli. harboring 
plasmids encoding either mutant or wild type B-lactamases. 
The cells were grown to late log-phase (O.D. at 600 nm - 1} 
and the absorbance at 600 nm was measured. The cells were 
pelleted by centrifugation and resuspended in loading 
buffer [10% (vollvol) glycerol I 5% (vollvol) 2-mercaptoe-
thanol 1 3% (wtlvol) sodium dodecyl sulfate I 62.5 mM Tris-
HCl, pH 6.8 1 1 mM EDTA] and incubated 10 minutes at 95°C. 
Cells from cultures with slightly higher or lower densities 
were resuspended in proportionally greater or lesser volumes 
of loading buffer. A 20 ~1 aliquot wa~ loaded onto a 15-cm 
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12% polyacrylamide gel with a 2 em 4% stacking gel and elec-
trophoresed at 5 mA for approximately 12 hours. 
After electrophoresis, protein was transferred to nitrocel-
lulose according to the Bio-Rad procedure (26) as described 
in Chapter II. The protein blots were stained according to 
the Vectastain procedure (27) using antibody raised against 
B-lactamase in rabbits as described in Chapter II. 
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Results 
The synthetic segment used to introduce the Cys 77 
--> Ser mutation also introduced a silent mutation that 
results in a Nar I restriction site at 3924; these base 
changes are designated by asterisks in the synthetic oligonu-
cleotide segment given in the Materials and Methods section. 
After ligation of the synthetic segment into pBR322-CR7, 
transformed cells were spread onto L-agar containing 200 mg/1 
of ampicillin; this selection eliminated plasmids that lacked 
a synthetic segment or those that contained either inverted 
or repeated synthetic segments. Plasmids were isolated from 
cultures derived from nine of the ampicillin resistant colo-
nies. Restriction mapping with Nar I indicated that all nine 
of these colonies harbored plasmids that had received the 
synthetic fragment. The sequence was verified by sequencing 
two of the mutants (pBR322-DC9 = Cys 77 --> Ser and pBR322-
DC71 = Thr 71 --> G1n, Cys 77 --> Ser) through the region in 
which the synthetic fragment was introduced. 
After introducing the Cys 77 --> Ser mutation into 
each of the 19 mutants at residue 71, three tetracycline 
resistant colonies from each of these 19 sets of double 
mutants were used to inoculate L-agar plates containing 
200 mg/1 of ampicillin; these plates were incubated at 30°C 
and 37oc. For the Cys 77 --> Ser mutants, only cells con-
taining enzyme with Thr at residue 71 grew at 37°C. However, 
cells containing Cys 77 --> Ser mutants with Val, Thr, Ala, 
Cys, Leu, Pro, Ile, Ser, His, and Met at residue 71 grew at 
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30°C; these same strains grew when the plates contained 500 
~g/1 of ampicillin and were incubated at 30°C and at room 
temperature. Cys 77 --> Ser mutants with Gly, Lys, Phe, Tyr, 
Glu, Asp, Arg, Asn, Gln, and Trp did not confer cellular 
resistance to ampicillin for any of the conditions tested. 
More accurate values for the level of antibiotic resis-
tance provided to cells by the mutant B-lactamases were 
determined by spreading cells onto an agar plate with a 
continuous concentration gradient of antibiotic. The maximal 
concentrations at which colonies were established for each of 
the mutants are listed in Table I. Cells containing the Thr 
71 --> Cys, cys 77 --> Ser mutant grew at 30°C when picked 
and inoculated onto L-agar plates containing 500 mgjl of 
ampicillin, but not when spread onto gradient plates; this 
probably resulted from the inoculum effect and, consequently, 
this mutant is designated as having trace activity in 
Table I. 
Whole cell extracts from approximately 2 X 108 E. coli. 
cells harboring the various wild type and mutant plasmids 
incubated either at 30°C or 37°C was electrophoresed in 
denaturing sodium dodecyl sulfate I polyacrylamide gels and 
then transferred to nitrocellulose. Figure 3 shows antibody 
stains of these blots. All of the mutant B-lactamases are 
present, but the quantity is greatly reduced, even at 30°C, 
when compared to the wild type or Cys 77 --> Ser enzymes. 
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Discussion 
Many factors influence the level of antibiotic resis-
tance observed for cells containing the wild type and mutant 
plasmids, including: plasmid copy number, rate of transcrip-
tion, stability and rate of translation of the mutant mRNA's, 
stability of pre-B-lactamase in the cytoplasm, rate of pro-
cessing and secretion, stability of the protein in the peri-
plasm, and, finally, the intrinsic enzymatic activity. 
As discussed in Chapter II, previous results (18) sug-
gest that for the conditions used in our experiment, muta-
tions in this region of the plasmid do not alter plasmid 
copy number, transcription, or translation. For a given 
amino acid mutant at residue 71 in B-lactamase, the maximal 
level of in vivo antibiotic resistance conferred by this 
mutant is not influenced by the use of various codons for 
that amino acid; similarly, no apparent differences arise 
from use of a particular codon in the double mutants 
described here. If mutations in this region of the plasmid 
did affect these cell processes, one would expect such dif-
ferences to exist. 
Mutations may, however, affect processing and secretion 
of proteins (28) and thereby alter the observed antibiotic 
resistance of cells. Mutants such as Thr 71 --> Ser and Ser 
70 --> Thr and the double mutant Ser 70 --> Thr, Thr 71 --> 
Ser are processed and secreted at a normal rate in Salmonella 
typhirnurium (29); the Cys 77 --> Ser mutant is also secreted 
at a normal rate in this system (D. Botstein, personal corn-
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munication). Previously, we observed abundant quantities 
of mature B-lactamase in cells growing at 30°C that contained 
any of the 19 mutations at residue 71 (18); in Figure 3, 
abundant quantities of the Cys 77 --> Ser mutant are pre-
sent . Figure 3 also shows no buildup of pre-B-lactamase 
for any of the mutant enzymes. Together, these facts suggest 
that the rate of processing and secretion of the various 
mutant B-lactamases described here do not differ signifi-
cantly from each other or from the wild type enzyme. 
However, stability of the wild type and mutant B-lacta-
mase protein in the periplasm, which will affect the quantity 
of enzyme capable of catalysis, obviously affects the antibi-
otic resistances observed here. Figure 1 shows that for the 
Cys 77 --> Ser mutant, all of the mutations at residue 71 
result in a dramatic decrease in proteolytic stability for 
the protein, even at 30°C. The stability of these mutants 
apparently is decreased greatly from that of the single 
mutants at residue 71 (with the disulfide bond intact) (18) 
and from that of the Cys 77 --> Ser (with Thr at residue 71); 
the Cys 77 --> Ser mutant is apparently more stable than any 
of the residue 71 mutants. The apparent order of stability, 
therefore, is: wild type > Cys 77 ~ Ser > single mutants 
with Thr 71 ~ any other amino acid > double mutants with 
Cys 77 ~ Ser, Thr 71 ~ any other amino acid. 
The intrinsic enzymatic activity will also affect the 
antibiotic resistance of cells containing the mutant B-lacta-
mases. Precise values can be obtained only with purified 
78 
protein; however, the instability of these mutants makes 
purification and characterization difficult. The data in 
Table I show that several of the mutant B-lactamases retain 
catalytic activity when the disulfide bond is removed . 
Mutant enzymes with Gly, Asn, Gln, Glu, and Phe at residue 
71, although active when the disulfide bond is present (18), 
do not confer ampicillin resistance to cells when the Cys 77 
--> Ser mutation is introduced. Mutant enzymes with Ala, 
Val, Leu, Ile, Met, Pro, His, and Ser at residue 71 all have 
low levels of activity on ampicillin; the Thr 71 --> Cys, Cys 
77 --> Ser mutant has only trace activity. Apparently, these 
mutant enzymes at least partially maintain a population of 
active conformations; however, from these experiments we 
cannot determine whether the kcat andjor Km values for the 
mutant enzymes are intrinsically altered or whether the 
relative amount of enzyme in active and inactive conforma-
tions is changed. 
Ampicillin resistance provided by the Thr 71 --> Ile, 
Cys 77 --> Ser mutant is greater than that provided by double 
mutants with the other nonpolar amino acids at residue 71; 
this may result from slightly greater stability, which is 
similar to observations for the Thr 71 --> Ile single mutant 
(18). However, this result is in contrast to the s. aureus 
PC1 B-lactamase in which Thr 71 --> Ile results in an inac-
tive enzyme (18). Structural studies of the PC1 mutant 
indicate that the enzyme is not folded properly; the authors 
propose that this mutation blocks a late step in the folding 
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process such that the enzyme cannot assume its active confor-
mation (19). For the RTEM-1 Thr 71 --> Ile, Cys 77 --> 
Ser mutant, either a different folding mechanism is operating 
or the structure of this enzyme allows it to accommodate 
mutations at residue 71 more readily than the PCl enzyme. 
Interestingly, the mutant with Thr 71 --> His, Cys 
77 --> Ser is resistant to higher levels of ampicillin than 
the mutant with Thr 71 --> Ser, Cys 77 --> Ser; the single 
mutants Thr 71 --> His and Thr 71 --> Ser are phenotypically 
indistinguishable on ampicillin (18). One would not expect 
His to be a suitable replacement for Thr structurally or 
catalytically, certainly not comparable to or better than 
Ser. 
The results presented here suggest two general conclu-
sions. First, the disulfide bond between Cys 77 and Cys 123 
in the RTEM-1 S-lactamase encoded by pBR322 can stabilize the 
enzyme when mutations are introduced at residue 71. One 
could speculate that since the disulfide bond is separated 
from Thr 71 by only five residues, instabilities that might 
propagate along the peptide chain could be limited by the 
disulfide cross-link. 
A high resolution crystallographic determination of 
the structure of a class A S-lactamase has not yet been 
accomplished. However, the structure of D-alanyl carboxypep-
tidase-transpeptidase from Streptomyces R61 has been solved 
at 2.8 A resolution (30). This protein is probably structur-
ally related to the class A S-lactamases (8) and, indeed, 
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shows a high degree of structural homology to Bacillus lichen-
iformis 749/C S-lactamase (31). In the structure of this 
carboxypeptidase, the residue seven amino toward the carboxy 
terminal end from the nucleophilic Ser (Ser 70 in S-lacta-
mase) is positioned in the A a-helix that immediately follows 
(toward the carboxy terminal end) the loop containing resi-
dues believed to be analagous to Ser 70 and Lys 73 in S-lac-
tamase. By analogy with this structure, Cys 123 would then 
be positioned in a long (95 amino acid) random coil region 
that extends from the end of the A helix and connects to the 
beginning of a B sheet region (SA). - Interestingly, this 
random coil segment passes near the region in which Thr 71 
would be located. Possibly, therefore, Thr 71 and the disul-
fide bond may be important for positioning this section of 
the polypeptide chain. 
The second general conclusion suggested by these experi-
ments is that the threonine side chain can perform a unique 
and essental role in the conformational stability of pro-
teins; apparently both the hydroxyl and methyl groups of 
Thr 71 are necessary for proper structural stability in 
B-lactamase. Even Ser, whose side chain differs from Thr by 
only a single methyl group, cannot adequately replace Thr. 
The experiments presented here should reflect more accurately 
the structural role of Thr 71; in previous experiments with 
mutations at residue 71 (18) the disulfide bond stabilizes 
the mutant enzymes. The decrease in stability that results 
from replacing Thr with any other amino acid is much more 
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striking in the absence of a disulfide bond. 
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Conclusion 
The results presented here demonstrate that the presence 
of a disulfide bond stabilizes the residue 71 mutants of 
B-lactamase. Of the class A B-lactamases, only the RTEM 
enzymes contain a disulfide bond and, interestingly, the RTEM 
enzymes are the least homologous to other class A B-lacta-
mases; one could speculate that the presence of a disulfide 
bond could allow greater freedom for structural variation 
arising from mutations. 
Site saturation of residue 71 in the Cys 77 --> Ser 
mutant of B-lactamase has again produced some surprising 
results. For example, His apparently can replace Thr more 
effectively than Ser at residue 71; the Thr 71 --> Cys, Cys 
77 --> Ser mutant exhibits only very low levels of activity, 
unlike its singly mutant counterpart; and the Thr 71 --> Ile, 
Cys 77 --> Ser mutant again exhibits higher levels of activ-
ity than substitution with other nonpolar residues. 
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Figure III-3. Electrophoretic blots of the Cys 77 --> 























































































































































































































































































































































Table I - Maximal level of ampicillin resistance of 
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CHEMICAL SYNTHESIS OF OLIGONUCLEOTIDES USING 
THE PHOSPHORAMIDITE METHOD 
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Abbreviations 
DCC - Dicyclohexylcarbodiimide 
DCA - Dichloroacitic acid 
dA - Deoxyadenosine 
dC - Deoxycytosine 
dG - Deoxyguanine 
dT - Deoxythymidine 
DMT - Dimethoxytrityl 
TEAoAc - Triethylammonium acetate 
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Introduction 
Several diverse areas of biochemical research such 
as studies of the structure and dynamics of the DNA double 
helix (1,2,3), cloning and sequencing of various genes (4,5), 
oligonucleotide-directed mutagenesis (6,7), and gene synthe-
sis (8,9,10) require a convenient and reliable source of 
oligonucleotides with specified sequences. Consequently, 
intense effort has focused on developing efficient, reliable 
techniques for chemical synthesis of oligonucleotides. The 
synthesis essentially involves creating a phosphate diester 
linkage between the 3'-hydroxyl of one deoxyribonucleoside 
and the 5 1 -hydroxyl of another. However, since one must 
repeat the reactions many times to build an oligonucleotide 
sequence, minor inefficiencies such as incomplete reactions 
or side reactions (such as reactions with the nucleotide 
bases) will quickly limit the length and quality of oligo-
nucleotide sequences that one can obtain from chemical syn-
thesis. 
Khorana and co-workers developed the first workable 
oligonucleotide synthesis in the early 1960's (11). The 
reaction was a DCC or Arso2cl catalyzed esterification of the 
3 1 -hydroxyl group of one nucleoside with the 5 1 -phosphate of 
a second nucleotide (Figure 2). Protecting groups prevented 
reaction at other nucleophilic sites on the purine or pyrimi-
dine base and the deoxyribose ring (Figure 1) (11); current 
methods for oligonucleotide synthesis utilize these same 
protecting groups. Although Khorana's method was successful, 
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each coupling required hours or even days to produce reason-
able yields; also, the charged phosphate backbone severely 
limited the selection of solvents making the chemistry rather 
difficult. 
Letsinger and co-workers solved the latter problem 
in 1967 with the "phosphate triester" method (12) in which an 
additional organic ester at the phosphate group resulted in a 
noncharged backbone. K. Itakura has improved several aspects 
of this method including the use of 1-(mesitylene-2-sulfonyl)-
3-nitro-1,2,4-triazolide as a coupling agent (13) for faster, 
more efficient reactions; 30-60 minutes produced 90+% yields. 
Letsinger and co-workers introduced a faster, more 
efficient method in 1974 (14) that utilized highly reactive 
phosphochloridate derivatives of the nucleosides. This "phos-
phite" method (Figure 2) allowed one to couple two deoxyribo-
nucleotides with greater than 90% yields in less than 5 
minutes. However, the instability of the phosphochloridate 
compounds made this method difficult and unreliable. 
Serge Beaucage, working in M. Caruthers group, developed 
a more reliable method (15) by utilizing phosphoramidite 
derivatives (more specifically N,N-dimethylaminomethoxyphos-
phine derivatives) of the nucleosides (Figure 2). These 
phosphoramidites are stable in basic conditions but become 
activated in the presence of weak acids and couple with 
efficiencies greater than 90% in only 3-5 minutes . This 
phosphoramidite method for synthesis of oligonucleotides has 
become the method of choice in most groups; although 
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Itakura's improved triester method is also popular. 
The development of methods for solid-phase synthesis of 
oligonucleotides (16,17,18) was essential for an effective 
oligonucleotide synthesis. By coupling the first deoxyribo-
nucleotide to solid supports such as polystyrene or silica 
gel, one could remove reagents by filtration and thereby 
avoid losses due to purification and isolation at each step 
of the synthesis. 
The general scheme for solid phase synthesis of oligo-
nucleotides using the phosphoramidite chemistry is presented 
in Figure 3. Briefly, the reactions for each cycle of 
synthesis are: (i) removal of the 5'-dimethoxytrityl group 
with a weak acid, (ii) condensation of a new nucleoside 
phosphoramidite to the 3 1 -end of the growing oligonucleotide 
chain (which is bound to the solid support), (iii) capping of 
unreacted 5 1 -hydroxyl groups using acetic anhydride, (iv) 
oxidation of the phosphine backbone with iodine. 
I have improved several aspects of the oligonucleotide 
synthesis using the phosphoramidite chemistry. First, 
suzanne Horvath and I have improved the stability of the 
phosphoramidites (stored under argon as a dry powder) from 
2-3 weeks to 8+ months. Second, I have reduced the cycle 
time for manual sythesis to 35 minutes per cycle. Third, I 
have increased the efficiency of the coupling reaction to an 
average of 97 or 98% per cycle. I have synthesized several 
oligonucleotides for use in a variety of experiments : I have 
also developed an HPLC method for purifying ~mole quantities 
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of oligonucleotides. 
Presently, manual synthesis of oligonucleotides is 
necessary only when large amounts are required or non-routine 
syntheses are performed. Several companies, such as Applied 
Biosystems, Beckman, and Vega have developed extremely effi-
cient machines that routinely synthesize oligonucleotide 
sequences up to 100 bases in length. The Applied Biosystems 
machine uses the phosphoramidite chemistrY on a solid supper~ 
consisting of controlled pore glass. Yields above 98% per 
cycle are routine and very high quality product can be 
obtained when the machine is properly maintained and operated 
(19). 
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Materials & Methods 
All solvents and reagents not specified here were from 
Aldrich Chemical co.; Aldrich gold label chemicals were 
purchased if available. Sodium sulfate, methanol, and tetra-
hydrofuran were from Baker Chemical Co •• Triethylamine 
was from Kodak (Eastman-Kodak). The silica gel was either 
VydacT.M. A (from The Separations Group, Hesperia, CA) or 
Fractosil (from American Scientific, 300-700 A pore size). 
The 3 A molecular sieves were from Aldrich and the 4 A mol-
ecular sieves were from Linde (Union Carbide). N,N-Dimethyl-
aminotrimethylsilane was from Petrarch Systems, Inc. or 
Aldrich. Dichloromethoxyphosphine was from Aldrich (this 
brand was the most reliable). The alumina was Woelm N, 
Akt 1 (Woelm Pharma, West Germany). Bio-Gel P-4, polyacryl-
amide, and N,N-methylenebisacrylamide were purchased from 
Bio-Rad. 
Preparation of Solvents 








Distilled from calcium hydride 
Distilled from calcium hydride 
Distilled from calcium hydride 
Distilled from calcium hydride 
Distilled from p-toluensulfonyl 
chloride then calcium hydride 
Distilled from p-toluensulfonyl 
chloride then calcium hydride 
Distilled from Potassium Hydroxide 






Distilled from phosphorus pent-
oxide, passed over alumina 
immediately prior to use 
400 ml was refluxed over 4.6 g of 
sodium and 10 g benzophenone 
until this solution was purple, 
then distilled 
Dried over molecular sieves 
Dried over molecular sieves 
Methanol, chloroform, acetonitrile, and nitromethane were 
stored over 3 A molecular sieves and toluene, dioxane, puri-
dine, 2,6-lutidine, diisopropylethylamine, and tetrahydro-
furan were stored over 4 A molecular sieves. 
Derivatization of Silica Gel (18) 
1. Preparation of "amino" silica gel. 
Vydac A silica gel (12 g) was shaken at room temperature 
with 13 ml (55.3 mmoles) of 3-aminopropyltriethoxysilane in 
120 ml of toluene for 12 hours. Boiling stones were added 
and the mixture was refluxed for 18 hours. The silica gel 
was filtered and washed with: 4x50 ml of toluene, 3x50 ml of 
methanol, and 2x50 ml of 1:1 methanol/water. Methanol/water 
(1:1, 50 ml) was added and the mixture was shaken overnight. 
The silica gel was filtered, washed with 2x50 ml of methanol 
and 2x50 ml of ether and dried overnight in a vacuum desica-
tor. Anhydrous pyridine (50 ml) and trimethylsilyl chloride 
(7 ml, 55.2 mmoles) were added and the mixture was shaken 
overnight. The silica gel was filtered, washed with 5x50 ml 
of methanol and 3x50 ml of ether and dried overnight in a 
vacuum desiccator. 
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2. Synthesis of 3 1 -succinyl nucleosides. 
Protected and tritylated nucleoside (5 mmoles) was 
dissolved in 10 ml of anhydrous pyridine at room tempera-
ture; dimethylaminopyridine (0.6g, 4.9 mmoles) and succinic 
anhydride (0.7g, 7 mmoles) were added and the solution was 
stirred overnight at room temperature. The pyridine was 
evaporated (roto-vac) to give a gummy product. Toluene (10 
ml) was added and then evaporated (roto-vac) to give a foam. 
The foam was dissolved in 20 ml of dichloromethane and pre-
cipitated in 450 ml of 1:1 hexanejether at room temperature. 
The product (a white powder) was filtered and dried overnight 
in a vacuum desiccator. 
3. Coupling of succinylated nucleosides to amino silica 
gel. 
The p-nitrophenyl ester of the succinylated nucleoside 
was prepared by dissolving succinylated nucleoside (3.5 
mmoles), DCC (3.5 mmoles), and p-nitrophenol (3.5 mmoles) in 
12 ml of dioxane and 1 ml of pyridine. The solution was 
shaken for 2 hours at room temperature. Dicyclohexylurea 
from the reaction was filtered and rinsed with 3 ml of pyri-
dine. The filtrates were combined and added to a suspension 
of 5 g of amino silica gel in 15 ml of DMF; this mixture was 
shaken 4 hours at room temperature. The silica gel was 
filtered and washed with 2x30 ml of DMF, 2x30 ml of dioxane, 
5x30 ml of methanol, and 2x30 ml of ether. The derivatized 
silica gel was dried overnight in a vacuum desiccator. 
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Synthesis of Nucloeside Phosphoramidites (15) 
1. Synthesis of Chloro-N,N-dimethylaminomethoxyphosphine 
Dichloromethoxyphosphine (25 ml, 0.266 moles) was 
stirred in an ice-acetone bath (-10° to -15°C). Dimethyl-
aminomethylsilane (42.1 ml, 0.289 moles) was added dropwise 
over a two hour period. The reaction was allowed to warm to 
room temperature and stirred for 1 hour. The product was 
distilled at 15 torr (b.p. 44-44.5°C). 31p-NMR was used 
to assess the purity (smoky = -179.5 ppm, dichloromethoxy-
phosphine = -189.56 ppm in deuterochloroform with respect to 
5% aqueous phosphoric acid. Yields were 60-70% of 98+% 
purity. 
2. Synthesis of nucleoside phosphoramidites. 
Protected 5'-DMT nucleoside (4 mmoles) was dissolved in 
12 ml of chloroform 1 3.2 ml of diisopropylethylamine. Smoky 
(1 ml) was added dropwise over a 10 minute period and the 
reaction was stirred at room temperature for 15-30 minutes. 
Ethyl acetate (40 ml) was added and the mixture was washed 
quickly with 4x60 ml of saturated NaCl. The organic phase 
was removed, dried over anhydrous sodium sulfate, and evapo-
rated (roto-vac) to give a white foam. The foam was dis-
solved in 12 ml of toluene and precipitated in 200 ml of 
hexane in a dry ice-acetone bath. 
overnight in a vacuum desiccator. 
The Condensation Cycle (19) 
The white powder was dried 
Yields were 60-80%. 
1. Cleavage of the dimethoxytrityl group. 
A saturated solution of zinc bromide 1 95:5 nitrome-
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thane:methanol was used for removal of the dimethoxytrityl 
group. For a 4 ~mole reaction, 1.5 ml of the zinc bromide 
solution was added three times and shaken for 3 min., 7 min., 
and 12 min. For 20 ~mole reactions, 2.0 ml of the solution 
was used. 
A solution of 3% dichloroacetic acid was used for 
faster, more efficient removal of the dimethoxytrityl group. 
For a 4 ~mole reaction, 1.5 ml of the solution was twice 
added and filtered immediately followed by a 1.5 ml, 30 
second reaction. A solution of 5% diisopropylethylamine (1 
ml) was added immediately after this DCA solution was 
removed. 
2. Condensation reaction. 
A 0.5 M solution of tetrazole in acetonitrile was made 
fresh every week. The nucleoside phosphoramidite (40 ~moles) 
was dissolved in 0.4 ml of this tetrazole solution immedi-
ately prior to condensation. This solution was added to the 
4 ~mole reaction and shaken for five minutes. For the 20 
~mole reactions, 200 ~moles of the nucleoside phosphoramidite 
was dissolved in 2 ml of the 0.5 M tetrazole solution. Yields 
ranged from 90-105% as measured by the DMT cation absorbance 
at 498 nm. 
3. Capping reaction. 
Acetic anhydride (0.1 ml) was added to 1 ml of a solu-
tion of dimethylaminopyridine in tetrahydrofuran 1 2,6-luti-
dine (3.5g DMAP, 20 ml lutidine, 80 ml THF). This was added 
immediately to the 4 ~mole reaction and shaken for 2 minutes. 
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4. oxidation 
A solution of 0.2 M iodine in THF:2,6-lutidine:water 
(2:1:1) was added to the reaction and was shaken for 2 
minutes; 1.5 ml was used for 4 ~mole reactions and 2 ml was 
used for 20 ~mole reactions. 
5. Cycle schedule. 
Zinc Bromide cycle 
1. Nitromethane wash 
2. Zinc Bromide cleavage 
3. Methanol wash 
4. Acetonitrile wash 
5. Coupling 
6. Acetonitrile wash 
7. Capping 
8. Acetonitrile wash 
9. Oxidation 
10. Methanol wash 
DCA cycle 
1. Toluene wash 
2. DCA cleavage 
3. DIPEA wash 
4. Acetonitrile wash 
5. Coupling 
6. Acetonitrile wash 
7. Capping 
8. Acetonitrile wash 
9. oxidation 
2 x 30 sec. 
1 x 3, 7, 12 min. 
3 x 30 sec. 
5 x 30 sec. 
10 min. 
2 x 30 sec. 
5 min. 
2 x 30 sec. 
5 min. 
5 x 30 sec. 
2 x . 30 sec. 
2 rinses, 1 x 30 sec. 
30 sec. 
5 x 30 sec. 
5 min. 
2 x 30 sec. 
2 min. 
2 x 30 sec. 
2 min. 
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10. Methanol wash 5 x 30 sec. 
Deprotection (20) 
Silica gel with 0.25 ~moles of the desired sequence 
was shaken for 45 min. in 5 ml of a solution of thiophe-
nol:triethylamine:dioxane (1:2:2). The mixture was centri-
fuged in a clinical centrifuge and the supernatant was 
removed. The silica gel was washed with lx5 ml dioxane, 5x5 
ml methanol, and lx5 ml ether. The silica gel was allowed to 
dry for 30 minutes. A concentrated ammonium hydroxide solu-
tion (1.5 ml) was added and the mixture was shaken for 4 
hours. The suspension was centrifuged and the supernatant 
was removed to another tube; the silica gel was washed with 
1 ml of concentrated ammonium hydroxide and this was added to 
the supernatant; the resulting solution was incubated at 50°c 
for 15 hours. The ammonium hydroxide solution was removed by 
evaporation at reduced pressure. Approximately 17 drops of 
80% acetic acid was added to the oligonucleotide and this 
solution was incubated at room temperature for 15 minutes; 
the acetic acid was evaporated at reduced pressure. The 
oligonucleotide was redissolved in 0.6 ml of 0.1 M triethyl-
ammonium acetate (pH 7.0) and this solution was aliquoted 
into five tubes, frozen on dry ice, and lyophilized. 
Purification 
1. Preparative Polyacrylamide Gel Electrophoresis . 
The preparative gels were 4 mm thick and approximately 
40 em long; the wells were 2 em wide. The concentration of 
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acrylamide used depended on the length of the oligonucleo-
tide: 20% (weight/volume) for less than 30 bases, 18% for 30 
to 50 bases, 15% for over 50 bases. Standard 20% polacryl-
amide-urea gels contained: 150 g urea (50% weight/volume), 
150 ml of a 38% acrylamide : 2% bis-acrylamide solution 
(weight/volume), 30 ml of 1M TBE, 3 ml of a 10% ammonium 
persulfate solution (weight/volume) -- this mixture was 
diluted to 300 ml and 150 ~1 of TEMED (N,N,N',N'-Tetramethyl-
ethylenediamine) was added just before the gel was poured. 
Approximately 0.05 ~mole of the oligonucleotide was dissolved 
in 40 ~1 of loading buffer (80% formamide, recrystallized, 50 
mM Tris-borate, pH 8.3, lmM EDTA, 0.1% bromophenol blue) and 
loaded into one well. The gel was run at 500 volts for 12 to 
15 hours or 700 to 1200 volts until the bromophenol blue was 
at the bottom of the gel (approximately 6 to 8 hours). 
The bands were visualized by uv shadowing in which 
a silica gel plate that contained a florescent indicator 
(240 nm) was placed beneath the gel and illuminated with 
a small, hand held short-wave UV light. The desired band was 
cut out with a razor blade (quickly to avoid UV damage to the 
DNA) and crushed between weighing paper. The pieces of gel 
were placed in a 1.5 ml eppendorf tube and covered with 
approximately 1.0 ml of NACS buffer A (0.2 M NaCl; 10 mM 
Tris-HCl, pH 7.2; 1 mM EDTA); the oligonucleotides were 
eluted overnight at 20°c. This mixture was placed in a 
quick-sep funnel and spun in a clinical centrifuge at setting 
5; the supernatant was collected. This solution was loaded 
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onto a NACS column that was prepared according to the 
instruction manual (21). The oligonucleotide was eluted 3 
times with 200 ~1 of solution B (1.0 M NaCl in 10 mM Tris-
HCl, pH 7.2 I 1 mM EDTA). The eluant was loaded onto a 
sephadex G-25 spin column equilibrated in 1110 TE (1.0 mM 
Tris-HCl, pH 81 0.1 mM EDTA) and prepared as follows: sepha-
dex G-25-50 was autoclaved in 1110 TE and the resin was 
pipetted into a quick-sep column to give a wet-bed volume of 
4 ml; these columns were spun in a clinical centrifuge at 
setting 3 for 2 minutes and at setting 5 for 3 minutes; the 
oligonucleotide solution was loaded onto the column and spun 
at setting 5 for 3 minutes; the column was rinsed by adding 
200 ~1 of 1110 TE and spinning at setting 5 for 2 minutes; 
the eluant was then loaded onto a second spin column and 
eluted as described above. The 200 ~1 wash from this second 
column brought the final volume to approximately 1.0 ml. 
The absorbance of this solution was measured at 260 
and 280 nm. The concentration was calculated as follows 
( 22) : 
X O.D. (260 nm) X 20 gg 
ml ml O.D. 
2. HPLC purification. 
x 1 mole base 
330 g I mole 




Two types of HPLC purification were developed: one 
for ~mole quantities of double and single stranded oligonu-
cleotides lO . bases in length and a second for sub-~mole 
quantities of single stranded segments ranging from 14 to 29 
bases in length. Both were done on a Waters ~bondapak C18 
reverse phase column (7.8 mm X 30 em). Buffer A was 0.1 M 
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triethy1ammonium acetate, pH 7.0 and buffer B was Aldrich, 
Gold label acetonitrile. The flow rate was 2.0 mljminute. 
All equipment was from Waters: model 6000A pumps, model 440 
absorbance detector, model 660 solvent programmer, and model 
U6K injector. 
a. Purification of ~mole quantities of oligonucleotides. 
Trityl groups were not removed after the deprotection as 
described previously. Approximately 2 ~mole was loaded per 
injection. A linear concentration gradient of 10 --> 28 % 
acetonitrile over a 40 minute period gave the best separa-
tion. Retention time for the desired double stranded DMT-DNA 
was approximately 60 minutes; retention times for single 
stranded DMT-DNA was 35-50 minutes. The desired peak was 
collected and the solvent was removed by evaporation 
(roto-vac) • 
After this initial purification, the oligonucleotide 
segments were detritylated with 80% acetic acid as described 
previously. Non-selfcomplementary oligonucleotides were now 
combined with their complementary strands. Approximately 1.5 
~mole of the detritylated, double stranded oligonucleotide 
was injected into the system and eluted with a linear concen-
tration gradient of approximately 8 --> 12 % acetonitrile 
over a 60 minute period; the concentration gradient that 
produced optimal separations had to be determined experimen-
tally for each sequence, however. The desired peak was again 
collected and the solvent was removed by evaporation 
(roto-vac) • 
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The DNA was redissolved in 1 ml of 10 mM methyl phos-
phonate, pH 7.5 and loaded onto a Bio-gel P-6 minus 400 mesh 
column (1.5 em O.D. X 60 em) that had been equilibrated with 
10 mM methyl phosphonate, pH 7.5. The column was run under 
mild air pressure at 6-10 ml per hour. The double-stranded 
fragment (10 b.p.) eluted after 23 ml of buffer had passed 
through the column and was contained in a total volume of 
approximately 2 ml. 
b. Purification of sub-~molar quantities of oligonucleotide . 
Approximately 0.05 ~mole (one aliquot of the crude 
mixture from the deprotection as described previously) was 
purified per injection. A linear gradient of 10 --> 12 % 
acetonitrile in 60 minutes was generally successful, but 
precise conditions for optimal separations had to be deter-
mined experimentally for each sequence. Retention times 
varied from 30 to 50 minutes. The desired peak was collected 
and the solvent was removed by evaporation in vacuo. 
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Results 
While working with Dr. Suzanne Horvath, eighteen oligo-
nucleotides were synthesized. These oligonucleotides varied 
from 10 to 17 nucleotides long, and from single sequences to 
mixtures of 64 sequences. Most of these have been used 
successfully (23,24); in cases where results were not 
obtained, factors other than the oligonucleotide were at 
fault. All of the sequences synthesized in Suzanne's lab 
were made using the ZnBr2 cycle described previously. This 
method reliably produced highly pure, biologically active 
oligonucleotides. 
Since then, I have synthesized several oligonucleotides 
in our lab for use by our research group. These are classi-
fied by cycle (ZnBr2 or DCA cycle) and scale (4 ~molar or 20 
pmolar). 
ZnBr2 cycle-4 umole scale 
1. BL-15 Cys77 --> Ser CCACTTAGCAGAACT 
Overall yield = 25.4 % 
Average yield = 91 % 
This sequence was used to convert Cys 77 to a Ser in 
B-lactamase (25). The sequence was made with protected 
DMT-nucleosides from Biosearch. The capping reaction was not 
used. An analytical polyacrylamide gel showed lighter than 
normal bands for the sequence and a smear appeared above the 
band for the 15-mer; this suggests that the capping reaction 
may be necessary for reasons besides capping unreacted 
chains. 
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2. BL-15 Thr71 --> Cys ATGATGAGCTGTTT 
Overall yield= 27.9 % 
Average yield = 91 % 
This sequence was made for converting Thr 71 to a Cys in 
B-lactamase. The sequence was made with protected DMTnucleo-
sides from Biosearch. The oligonucleotide showed a normal 
banding pattern on the gel. 
3. BL-15 ser70 --> Arg ATGATGCGCACTTTT 
overall yield = 46 % 
Average yield = 95 % 
This sequence was used to convert Ser 70 to an Arg 
(26) in B-lactamase. The sequence was made with protected 
DMT-nucleosides from American Bionuclear. More than the 
normal amount of product (15-mer) was observed on an analyti-
cal polyacrylamide gel. 
4. a-LP-1416 A 
AACGCCTGCATGG 
T G T 
T 
overall yield = 19.3 % 
Average yield = 89 % 
This sequence was used in attempting to isolate the 
gene for a-lytic protease from Lysobacter enzyrnogenes. 
The sequence was made using protected DMT-nucleosides from 
American Bionuclear. For sites with mixed compositions of 
bases, the silica gel was split into equal portions and the 
condensations were done separately. The ratio of bases from 
these reactions was corrected to be within 5 % of an equi-
molar mixture when the silica gel was recombined. The 
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reason for lower than normal yield was an unusually low 
yield (55 %) in condensation of the G closest to the 5' end 
of the sequence. I have no explanation for this low yield 
and it has not occurred before or since. 
5. a-LP-118 GGCGTAACCAT 
T G T 
Overall yield = 58 % 
Average yield = 94 % 
This sequence was also used in attempting to isolate the 
gene for a-lytic protease from Lysobacter enzymogenes. The 
sequence was made using protected DMT-nucleosides from Ameri-
can Bionuclear. The sites with mixed compositions of bases 
were made by mixing equal amounts of the appropriate bases. 
ZnBr2 cycle - 20 gmole scale 
The following sequences were made using protected DMT-
nucleosides from Biosearch, which have since proven impure. 
These sequences were made for use in structural studies of 
















The following sequences were made using protected DMT-
nucleosides from American Bionuclear. 
10. BL-15 Thr71 --> Met GATGAGCATGTTTAA 
Overall yield = 65 % 
Average yield = 97 % 
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This sequence was made with Yie-Hwa Chang and used 
to convert Thr to a Met in S-lactamase (27). 
11. SL-14 Lys73 - -> Arg AGCACTTTTAGAGT 
Overall yield = 51 % 
Average yield = 95 % 
This sequence was made with Jim Neitzel and used to 
convert Lys 73 to and Arg in S-lactamase (28). 
12. CSA-33 GGCGCGCTAACATCTCCCACAAAGACATGCCAA 
Overall yield= 25.1 % 
Average yield = 96 % 
This sequence was made with Michael Emerling and was 
used in attempting to synthesize the gene for the complement 
factor csa (29) • 
13. CSA-30 CACTCGGGTCAACGGCCCAGTTGCATGTCT 
Overall yield = 31.2 % 
Average yield = 96 % 
This sequence was made with Marilyn Tomich and was 
used in attempting to synthesize the gene for the complement 
factor csa (29). 
14. PLPlAT-29 AATTGGTCGACATGATCGACGTTCTGCTG 
Overall yield = 23.9 % 
Average yield = 95 % 
This sequence was made with Sheila Iverson and was 
used in attempting to synthesize the gene for plastocyanin 
( 3 0) • 
15. PLPlAB-25 TCCGTCGTCAGCACCCAGCAGAACG 
overall yield = 39.4 % 
Average yield = 96 % 
This sequence was made with Sheila Iverson and was 
used in attempting to synthesize the gene for plastocyanin 




Overall yield = 37 % 
Average yield = 96 % 
This sequence was used in attempting to introduce a Xma 
III restriction site near the 3'-end of Sindbis virus (31). 
17. SB-29 GCGTCTAGATTTTTTTTTTTTTTTTTTTT 
Overall yield = 34.2 % 
Average yield = 96 % 
This sequence was made with Reef Hardy and was used in 
attempting to introduce a Sal I site near the 5 1 -end of 
Sindbis virus (31). 
DCA cycles -- 20 umole scale -- The following sequences 
were made using protected DMT-nucleosides from American 
Bionuclear. These sequences were made for use in structural 




























Oligonucleotides purified by preparative poyacrylamide 
gel electrophoresis consistantly gave one dark band of appro-
priate length on analytical gels. This method is useful 
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for purifying sub-~mole amounts of DNA for use in biological 
experiments and is now routine . 
For purifying ~mole quantities of oligonucleotides, 
a preparative HPLC method was developed. Chromatograms 
(measured by absorbance at 254 nm) are presented in Figures 4 
to 9. Figure 4 shows the chromatogram of an analytical 
quantity of tritylated (GC) 5 used in determining conditions 
for optimal separations. Figures 5 and 6 show chromatograms 
of samples injected for purification of tritylated and detri-
tylated (GC)5. The tritylated samples were the crude reac-
tion mixtures obtained from deprotection and the detritylated 
samples were obtained by treating the purified tritylated 
samples with 80% acetic acid as described previously. 
Sequences purified in this manner showed a single band of 
appropriate length on analytical gels. Figures 7, 8 and 9 
show chromatograms of HPLC purifications of 0.05 ~mole quan-
tities of BL-15 Thr71 --> Met, BL-14 Lys7 3 --> Arg, and 
SB-24. These purified sequences showed a dark band of appro-
priate length on analytical gels, but several, very faint 
bands were also present. 
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Discussion 
The general scheme for solid phase synthesis of oligo-
nucleotides using the phosphoramidite chemistry is presented 
in Figure 3. We have focused primarily on three aspects of 
the synthesis: improving the stability of phosphoramidite 
derivatives of deoxyribonucleosides, decreasing the time 
required for the reaction cycle, and increasing the effi-
ciency of each reaction in the cycle. 
Previously, the stability of deoxyribonucleoside phos-
phoramidites was unpredictable; one to five weeks after 
synthesis, the deoxyribonucleoside phosphoramidites would 
suddenly become less reactive, resulting in low yields in the 
coupling reaction, and within two days these compounds would 
be inactive. This rapid decay in activity was a source of 
extensive frustration and confusion. Since extreme care in 
handling and storage of the phosphoramidite derivatives 
apparently had not improved their stability, we decided 
to investigate the quality of the nucleoside phosphoramidites 
and the reagents used in their synthesis. 
Dichloromethoxyphosphine was purchased from several 
sources (including Aldrich, American Bionuclear, and Special-
ty Organic Chemicals) and was found to contain from 2 to 20 % 
PC1 3 . We carefully distilled the dichloromethoxyphosphine 
until it was 99% pure (by NMR). This purified dichlorome-
thoxyphosphine was then used to synthesize the chloro-N,N-di-
methylaminomethoxyphosphine as described in the experimental 
section of this chapter. Careful fractional distillation of 
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chloro-N,N-dimethylaminomethoxyphosphine at reduced pressure 
(15 mm Hg) immediately after it was synthesized produced 
greater than 98% purity (by 31P-NMR). Nucleoside phosphor-
amidites synthesized with this chloro-N,N-dimethylaminome-
thoxyphospine were stable for eight or more months. The loss 
of activity that previously had plagued the oligonucleotide 
synthesis has not been observed since the purity of the 
chloro-N,N-dimethylaminomethoxyphosphine has been estab-
lished. We believe that a by-product produced during or 
carried through the synthesis of this compound, and which has 
a boiling point very near that of chloro-N,N-dimethylamino-
methoxyphosphine was responsible for the instabilities pre-
viously observed - perhaps dichloro-N,N-dimethylaminophos-
phine or some compound that could readily form an acid which 
will activate the phosphoramidites and result in hydrolysis 
or other undesirable side reactions. 
More recently, several groups have developed phosphor-
amidite derivatives that are more stable than the dimethyl-
amino compound. The N,N-diisopropylamino phosphoramidites 
(32) have replaced the N,N-dimethylamino derivatives in most 
laboratories. A B-cyanoethyl derivative (33) is also more 
stable than the dimethyamino phosphoramidite and also makes 
the thiophenol reaction in deprotection of the oligonucleo-
tide unnecessary; slightly longer coupling times are required 
for this derivative, however. 
We have also studied methods for optimizing each step of 
the reaction cycle. The first step, cleavage of the dime-
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thoxytrityl (DMT) group from the 5 1 end of the preceeding 
base, previously utilized the Lewis acid ZnBr2 (34), since 
strong protic acids can lead to depurinization of oligonucle-
otides. Although removal of the DMT group with ZnBr2 is 
sufficiently effective, the reaction is slow, requiring 15 to 
25 minutes for a complete reaction. Trichloracetic acid is 
fast and has been used extensively, but substantial amounts 
of depurinization can occur during prolonged exposures (35). 
We have used dichloroacetic acid (PKa's: TCA = 0.64, DCA= 
1.26) which cleaves the trityl group in less than 1 minute. 
A solution of 5% diisopropylethylamine in toluene was added 
immediately after the cleavage reaction to quickly neutralize 
any remaining acid. Treatment of the aLP-1416 sequence with 
3% DCA in toluene for one hour produced no detectable change 
in the banding pattern when the oligonucleotide was depro-
tected and run on an analytical polyacrylamide gel. This 
method of cleaving the DMT group has greatly reduced the 
cycle time and also has resulted in slightly greater yields 
per cycle. 
For the coupling reaction, tetrazole, a very weak acid 
is added to activate the phosphoramidite immediately prior to 
coupling (15); this acid probably protonates the lone pair of 
electrons on the amino nitrogen. The coupling reaction is 
fast and efficient; it is complete within 3 minutes. 
Slightly longer coupling times were used to allow for incon-
sistancies in mixing. The first two couplings frequently 
required longer (10-15 minutes) coupling times; the source of 
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this effect is unknown. 
The capping reaction was thought to be optional. How-
ever, our results indicate that besides capping unreacted 
5 1 -hydroxyl groups, this reaction may serve an additional 
function. When this reaction was omitted, an analytical 
polyacrylamide gel showed a dramatic decrease in the quantity 
of oligonucleotide (despite normal reaction yields) and a 
large smear above the expected position of the oligonucleo-
tide. These results indicate that the capping reaction is 
suppressing side reactions, perhaps some that result in 
branching of the oligonucleotide chain. 
The oxidation reaction is complete within one minute. 
The only problem encountered with this reaction occurred when 
using an iodine solution that was several months old; 
although the cycles had produced normal yields, no oligo-
nucleotide was observed on an analytical gel after deprotec-
tion. The unoxidized phosphate backbone was probably cleaved 
before or during the deprotection. Treatment of non-depro-
tected oligonucleotide with fresh iodine solution did not 
salvage the sequences suggesting either cleavage had occured 
during the reactions or an intermediate complex that is not 
easily oxidized had formed. Subsequently, fresh iodine 
solution was made every month. 
The efficiency of coupling in each reaction cycle, 
as measured by the absorbance of the trityl cation after 
each cycle, averaged 91% using the initial ZnBr2 procedure 
(19). All attempts to increase the yields using this pro-
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cedure were unsuccessful. However, after several problems 
with protected nucleosides from Biosearch, protected nucleo-
sides from American Bionuclear were purchased and used in the 
synthesis. Immediately, average yields of 95% per cycle 
were obtained. Development of the DCA cycle further 
increased the yields to 97-98% per cycle. Recently, by 
using controlled pore glass as the solid support, yields 
of 99% per cycle have been obtained (19,32). 
We have used two methods to purify oligonucleotide 
sequences synthesized in our lab: preparative polyacrylamide 
gel electrophoresis and HPLC. For amounts of oligonucleo-
tides less than 1 ~mole, both preparative gels and HPLC have 
been used successfully. Examples of HPLC purification of 
such quantities are presented in Figures 7 thru 9. Oligonu-
cleotides purified by this method showed a dark band of 
expected length on analytical polyacrylamide gels, but trace 
amounts of oligonucleotides with shorter lengths could also 
be seen. These shorter oligonucleotides were very minor 
components (well below 1%) and did not interfere with the 
experiments (27,29,30). Oligonucleotides purified by prepara-
tive gel electrophoresis showed no trace of these smaller 
sequences. 
For purifying ~mole quantities of oligonucleotides, 
only the HPLC method is practical; examples of chromatograms 
from these purifications are shown in Figures 5 and 6. These 
sequences were first purified while still containing the 
trityl groups on the 5'-ends of the oligonucleotide to sepa-
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rate them from any sequences that were capped or otherwise 
terminated during the synthesis. The trityl groups were 
removed after this initial purification and the sequences 
were again purified by HPLC. Sequences purified in this 
manner showed only one dark band on analytical polyacrylamide 
gels. 
The success of purification by HPLC requires very high 
quality instrumentation. c18 reverse phase columns were the 
most successful; other columns including DEAE, SAX, and c4 
separated less well in our system. The affinity of oligonu-
cleotide sequences for the c18 resin is very narrowly defined 
and, consequently, separation of similar sequences is suc-
cessful only in a very narrow solvent range. High quality 
pumps are required for such precise gradients. The most 
frequent problem encountered with our system resulted from 
minor failures in the check valves; although such valves 
functioned sufficiently well when using rapid gradients, 
minor fluctuations in the very narrow gradient required here 
produced unworkable results. 
Presently, manual synthesis of oligonucleotides is 
necessary only when large amounts are required or non-routine 
syntheses are performed. Several companies, such as Applied 
Biosystems, Beckman, and Vega, have developed extremely 
efficient machines that routinely synthesize of oligonucleo-
tide sequences up to 100 bases in length. The Applied Bio-
systems machine uses the phosphoramidite chemistry on a solid 
support consisting of controlled pore glass. Yields above 
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98% per cycle are routine and very high quality product can 
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Figure AI-2. Schemes for DNA synthesis. 














Figure AI-3. Scheme for solid phase synthesis of oligonuc-
leotides using the phosphoramidite chemistry. 
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Figure AI-3 (continued) 
Synthesis or Deoxynucleos1de "Phosphora~~idi tes" 
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Figure AI-3 (continued) 
Deprotecti CJ'l 
OCH-:~ 
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@-sH, TEA, Dioxane 
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Figure AI-6. HPLC chromatogram of preparative quantity 
of (GC) 5 • Gradient was 8 --> 12% acetonitrile I 0.01 M 
TEAoAc in 50 minutes. 
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0 _10 15 20 25 )0 35 40 
Figure AI-7. HPLC chromatogram of BL-15 Thr71--> Met. 
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Figure AI-8. HPLC chromatogram of SB-24. Gradient was 
10 --> 12% acetonitrile 1 0.1M TEAoAc in 20 minutes. 
0 
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Figure AI-9. HPLC chromatogram of BL-14 Lys73 --> Arg. 
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Site-saturation studies of P-lactamase: Production and 
characterization of mutant P-lactamases with all 
possible amino acid substitutions at residue 71 
(mutqenesis/enzymatlc catalysla/proteiD stnacture-llmctlon relationships/proteiD ltabWty) 
STEVE C. SCHULTZ AND JOHN H. RICHARDS 
Division of Chemistry and Cbemical Elllineerin&, California lnstitute ofTechnoJosy, Pasadena, CA 91W 
Communicated by Norman Davidson, October 29, 1985 
ABSTRACT A mutagenic technique that "saturates" a 
particular site ID a protein with all possible amino acid 
substitutions was used to study the role ol residue 71 In 
IJ-Iactamase (EC 3.5.2.6). Threonine Is conserved at residue 71 
In all class A IJ-Iactamases and Is adjacent to the active site 
Ser· 70. Alll9 mutants or the enzyme were characterized by the 
penam and cephem antibiotic resistance they provided to 
Escherichill coli LSI cells. Surprisingly, cells producing any ol 
14 or the mutant IJ-Iactamases displayed appreciable resistance 
to ampicillin; only cells with mutants having Tyr, Trp, Asp, 
Lys, or Arg at residue 71 bad no observable resistance to 
ampicillin. However, the mutants are less stable to cellular 
proteases than wild-type enzyme Is. These results suggest _that 
Tbr· 7lls not essential for binding or catalysis but Is Important 
for stability of the IJ-Iactamase protein. An apparent change In 
specificity Indicates that residue 71 Influences the region or the 
protein that accommodates the sldt chain attached to the 
IJ-Iactam ring of the substrate. 
The creation of mutant proteins with specific changes in 
amino acid sequence by oligonucleotide-directed mutagene-
sis (1, 2) affords a general method for studies of the relation-
ship between structure and function. Recently, this approach 
has been applied to several enzymes, including trypsin (3), 
dihydrofolate reductase (4), aspartate carbamoyltransferase 
(5), tyrosyl-tRNA synthetase (6, 7), triosephosphate isomer-
ase (8, 9), lysozyme (10), and p.lactamase (11 , 12). Insights 
obtained from x-ray crystallography, computer modeling, 
sequence homologies, and catalytic mechanism greatly assist 
in predicting the consequences of a particular mutation on 
protein function. However, even then a particular amino acid 
substitution often causes a surprising change in activity; a 
thorough study of the role of an important residue requires 
substitution with all 19 other amino acids (site saturation). 
Such a study was recently reponed (13) for residue 12 in the 
c-Ha-ras 1 gene; in this case the mutants were generated by 
oligonucleotide-directed mutagenesis. All 19 amino acid 
substitutions were also produced for residue 222 in subtilisin 
by a technique similar to the one used here (14). 
As an approach to structure-function studies, site satura-
tion becomes particularly attractive under two conditions: (I) 
a procedure exists for efficiently generating the appropriate 
mutants and (il) the protein in question affects the phenotype 
of cells such that one can easily screen for mutants that 
perform a particular function . One can extend this approach 
to the simultaneous saturation of two or more sites in a 
protein to assess the effect of combinations of residues on 
protein function or, perhaps, to create a novel activity. 
Site saturation can be accomplished by introducing into the 
gene at the codon for the residue of interest a mixture of 
The publication costs of this article were defrayed in part by paae cbarae 
payment. This article must therefore be hereby marked .. advtrtiument" 
in accordance with 18 U.S.C. 11734 solely to indicate this fact . 
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nucleotides: A, T, G, and Cat the frrst two positions, G and 
C at the third position. This mixture of oligonucleotides, 
which codes for all 20 amino acids and the amber codon, can 
be readily introduced into the gene as a "cassette" when 
unique restriction sites are conveniently nearby. (If desired, 
appropriate mixtures of oligonucleotides can be used to 
encode a particular subset of amino acids.) 
We have applied site saturation to the study of pBR322-
encoded P.lactamase (EC 3.5.2.6). This is an RTEM-1 
enzyme (12, 15) originally taken from R factor R1 (16, 17) that 
catalyzes the hydrolysis of the P.lactam ring of penam and 
cephem antibiotics (18). This activity confers resistance to 
these antibiotics on cells that produce the enzyme and 
thereby provides a convenient screening procedure to assess 
the activities of mutants. The class A p.lactamases contain a 
conserved triad (Ser-Thr-Xaa-Lys) (19) at the catalytic site; 
this site includes Ser-70, whose hydroxyl group opens the 
p.lactam ring (20, 21). This study focuses on the conserved 
Thr-71, whose role ira the activity of p.lactamase is unknown. 
Restriction sites that flank the codon for Thr-71 were 
introduced into pBR322 by oligonucleotide-directed muta-
genesis; an Ava I site at nucleotide 3972 and a Sea I site at 
nucleotide 3937 were introduced. The DNA fragment be-
tween nucleotides 3972 and 3937 (Pro-62 to Val-74 in p. 
lactamase) was removed and replaced with a mixture of 
synthetic double-stranded oligonucleotides that included 32 
codons for residue 71 (codons for 20 amino acids and the 
amber codon). The resulting mixture of plasmids was used to 
transform Escherichia coli and the colonies were screened for 
their sensitivity to penam and cephem antibiotics. Surpris-
ingly, cells containing any of 14 of the mutant p.lactamases 
displayed appreciable resistance to ampicillin; only cells 
containing mutants with Tyr, Trp, Asp, Lys, or Arg at residue 
71 had no observable resistance to ampicillin. The mutant 
proteins show significantly increased sensitivity to proteol· 
ysis. 
MATERIALS AND METHODS 
Restriction enzymes and the large (Klenow) fragment of 
DNA polymerase I were purchased from Boehringer Mann-
beim. The T4 DNA ligase and T4 DNA kinase were obtained 
from Bethesda Research Laboratories. All antibiotics were 
from Sigma. The [a-32P)dTIP, 3000 I'Ci/mmol (1 Ci = 37 
GBq), was purchased from Amersham and b•·32P)ATP was 
from ICN. 
Oligonucleotides were synthesized by using the phos-
phoramidite chemistry (22) on the Applied Biosyste01s (Fos-
ter City, CA) DNA synthesizer, model 380A. Mixed oligo-
nucleotides were produced by using an equimolar mixture of 
the four nucleotide phosphoramidites or an equimolar mix-
ture of G and C nucleotide phosphoramidites in a normal 
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coupling reaction. The oligonucleotides were purified by 
preparative polyacrylamide gel electrophoresis. 
Bacteriophage M13 mp 8 was grown in E. coli 1M I03 (23) 
in 2x YT medium and prepared according to standard 
procedures (24). Plasmid pBR322 was grown in E. coli LSI 
(25) in LB medium (28). Plasmid purification (26) and cell 
transformations (27) were done by using standard proce-
dures. Selection involved growth in the presence of tetracy-
cline at IS mg/liter or ampicillin at IOO mg/liter unless 
otherwise stated. Numbering of pBR322 nucleotides is the 
one commonly used (28) . 
Oligonucleotide-directed mutagenesis was carried out on 
M13 mp 8 containing the 752-base-pair Pst 1-EcoRI fragment 
of pBR322. An Ava I site was introduced by changing T to C 
at residue 3972 and a Sea I site was introduced by changing 
A toT at residue 3939. Procedures used for the mutagenesis 
are described elsewhere (29, 30). To remove the preexisting 
Sea I site at 3846 on pBR322, the 6I-base-pair segment 
between Hincll at 39o7 and Sea I at 3846 was removed and 
replaced by a 6I-base-pair fragment that changed G to A at 
3846. 
To introduce the 20 amino acids at site 71, the following 
mixture of oligonucleotides was used. 
5 '-Cc-GAG-G.U-CGT-TTT-CCA-ATG-ATG-AGC[ ~C] TTC-.AAA-cT 
G-CTT-GCA-AAA-GGT-TAG-TAG-TCG GGG .UG-TTT-CA-5' 
TT 
The asterisk indicates a silent mutation that removes aDra 
I restriction site at 3943 and also decreases the self-comple-
mentarity of 6 (and possibly as many as IO) bases near this 
end of the individual strands. After purification, as described 
above, the mixtures of oligonucleotides were individually 
phosphorylated. They were then annealed by mixing 0.4 
pmol/ p.l of each strand and heating to 9s•c in IO mM 
MgCI2/50 mM Tris·HCl, pH 8, followed by gradual cooling to 
2o•c over a 45-min period. The resulting mixture of double-
EcoRI 
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stranded oligonucleotides (0.4 pmol) was mixed with the Sal 
I to Sea I fragment (0.04 pmol) and the Ava I to Sal I fragment 
(0.04 pmol) from pBR322-CR7 and pBR322-XNI, respective-
ly (see Fig. I). This mixture was ligated in IO mM MgCI2/50 
mM Tris·HCl, pH 8/0.5 mM ATP/5 mM dithiothreitol con-
taining IO units of T4 DNA ligase in a total volume of 50 p.l 
at Is•c for approximately I8 hr. The reaction mixture was 
extracted with phenol and the DNA was precipitated by 
addition of ethanol. The DNA was redissolved in 20 p.l of I 
mM Tris·HCI, pH 8/0.I mM EDTA; an aliquot (5 p.l) was 
used for transformation of E. coli LSI cells. After the 
transformation, I/IOth of the cells were plated on tetracy-
cline, producing 423 colonies. From these, I08 individual 
colonies were picked and inoculated onto tetracycline-con-
taining plates and were also tested for activity on the various 
substrates of P.,lactamase. Plasmids derived from these I08 
colonies were sequenced. 
For sequencing, the plasmids were digested with Ava I and 
the resulting 2962-base-pair fragment was isolated from a 
I .2% agarose gel by using DEAE-paper or the International 
Biotechnologies (New Haven, CT) UEA electroelutor. The 
fragment was labeled at T-3973 by using [a-32P)dTTP and the 
Klenow fragment of DNA polymerase I. The labeled frag-
ments were sequenced by using standard techniques (31). 
In L agar plates (28), an antibiotic concentration gradient 
was generated by raising one end of a Petri dish (8.5-cm 
diameter) 5 mm and pouring IS ml of L agar containing an 
appropriate concentration of antibiotic into the tilted dish. 
These were allowed to dry overnight. The plates were then 
placed on a flat horizontal surface and IS ml of L agar was 
poured on top; they were used immediately upon hardening. 
An aliquot (50 141) of a l:IO' dilution of a saturated culture 
(approximately 2 x I09 cells per ml) was spread over half of 
the plate. A standard mutant was plated on the other half; 
standards used were as follows: for ampicillin and ben-
zylpenicillin at 37•c and for 6-aminopenicillanic acid at 3o•c, 
Thr-71- Leu; for 6-aminopenicillanic acid at 37"C, Thr-71-+ 
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Protein for electrophoretic transfer blots was prepared by 
pelleting 1 x 1()9 E. coli LSI cells from a late-logarithmic-
phase culture containing tetracycline at 15 mg/liter in LB 
medium. These cells were resuspended in 100 ~ of 10% 
(vol/vol) glycerol/5% (vol/vol) 2-mercaptoethanol/3% sodi-
um dodecyl sulfate/62.5 mM Tris·HCI, pH 6.8, and incubated 
10 min at 95•c. An aliquot (20 ~I) was loaded onto a 15-cm 
12% polyacrylamide gel with a 2-cm 4% stacking gel. After 
electrophoresis, protein blots were prepared according to the 
Bio-Rad procedure (32); the transfer was at 50 V for 5 hr. 
Visualization was according to the Vectastain procedure (33) 
using rabbit antibody to P-lactamase. 
RESULTS 
Introduction of the Ava I 3972 and Sea I 3937 sites and 
removal of the Sea I 3845 site were verified by restriction 
mapping of the plasmids. The absence of other changes in the 
P-lactamase gene was verified by sequencing one of the 
mutants from the Pst I site through the residues of the 
structural gene encoding the protein N terminus. 
After ligation of the mixture of oligonucleotides into the 
plasmid, transformation of competent E. coli LS-1 cells gave 
423 colonies that were resistant to tetracycline. From these 
423 colonies, 108 were picked and inoculated onto tetracy-
cline plates and were also tested for resistance to ampicillin 
(10, 50, 100, and 500 mg/liter), benzylpenicillin (100 
mg/liter), 6-aminopenicillanic acid (10, 25, 50, and 100 
mg/liter), cephalothin (25, 50, and 100 mg/liter), and 
cephalexin (25 and 50 mg/liter). Ampicillin and cephalothin 
plates were incubated at 300C and 37•c; all others were 
incubated only at 37•c. This phenotype screening indicated 
that a change in antibiotic specificity and reduced stability, 
particularly at 37•c, were characteristics of some of the 
mutants. 
Plasmids derived from 105 of the colonies were sequenced 
from Ava I (3972) through Sea I (3937); Table 1lists the codon 
frequencies in this collection of colonies. The sequences were 
matched to the phenotypes determined above. Mutants with 
Tyr, Trp, Asp, Lys, or Arg at position 71 gave no resistance 
to any of the five antibiotics. A mutant with Phe was resistant 
to ampicillin at 100 mg/liter at 3o•c but sensitive even to low 
levels of ampicillin at 37•c. Mutants with Gly, Gin, or Glu 
produced resistance up to 100 mg of ampicillin or benzyl-
penicillin per liter at 37•c. Mutants with Ala, Val, Leu, De, 
Pro, His, Cys, Ser, Thr, or Asn gave resistance to ampicillin 
at >500 mg/liter and benzylpenicillin at> 100 mg/liter. Only 
mutants with His, Cys, Ser, or Thr were resistant to 6-
aminopenicillanic acid at >100 mgfliter, those with Gly, Ala, 
Val, Leu, De, Pro, Glu, or Asn were resistant to 25 mgfliter, and 
those with Met or Gin (although resistant to ampicillin) showed 
no resistance to 6-amino-penicillanic acid. Only the wild-type 
enzyme (Thr-71) conferred resistance to cephalothin and 
cephalexin at 37"C. A mutant, Thr-71-+ Ser, was resistant to 
Table 1. Distribution of codons for residue 71 
Codon No. Codon No. Codon No. Codon No. 
AAC 2 CAC 3 GAC 2 TAC 8 
AAG 6 CAG 3 GAG 3 TAG 2 
ACC 4 CCC 1 GCC 5 TCC 5 
ACG 2 CCG 2 GCG 4 TCG 3 
AGC 3 CGC 0 GGC 2 TGC 4 
AGG 4 CGG 2 GGG 1 TGG 5 
ATC 6 ere 1 GTC 0 TIC 1 
ATG 7 erG 2 GTG 2 TTG 6 
In addition to these 101 point mutations, there were three deletions 
at the Sea I site, six insertions at the Ava I site, one deletion at the 
Ava I site, four insertions in the codon for residue 71, and one 
insertion in the synthetic segment. 
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cephalothin at 50 mg/liter at 300C, but none of the other mutants 
grew in the presence of this antibiotic even at 30"C. 
More accurate values for the level of antibiotic resistance 
provided to cells by the mutant proteins were determined by 
spreading cells onto an agar plate with a continuous concen-
tration gradient of antibiotic. The maximal concentration at 
which colonies were established could then be observed. 
These phenotypic characteristics are summarized in Table 2. 
The values were independent of dilutions of cells higher by a 
factor of 2 or lower by a factor of 10 than those used in the 
experiments summarized in Table 2. Particularly noteworthy 
are the resistances at 37•c of cells producing the mutants 
Thr-71-+ De and Thr-71-+ His. In addition, the differences 
in levels of resistance at 3o•c versus those at 37•c are 
especially dramatic. 
Protein boiled in sodium dodecyl sulfate after extraction 
from cultures of the various mutants grown at 300C and 37•c 
was electrophoresed in denaturing sodium dodecyl sulfate/ 
polyacrylamide gels and then transferred to nitrocellulose. 
Fig. 2 shows antibody stains of these blots. Protein of the 
same size as P-lactamase is present for all mutants, but the 
quantity varies substantially for different mutants; this vari-
ation is greatly reduced at 30"C. We believe that the protein 
responsible for the band slightly above P-lactamase is pre-
P-Iactamase because it represents a protein of appropriate 
size and because this band is absent for the Thr-71-+ amber 
mutant. The blots suggest that the mutant proteins are 
processed normally but that mature mutant proteins are 
degraded, probably by E. coli proteases. 
DISCUSSION 
Importantly, for site-saturation studies, one should use 
mixtures of synthetic oligonucleotides having all specified 
codons at nearly equal frequencies; if codons for certain 
amino acids are present at low frequencies, the correspond-
ing mutants will be underrepresented, difficult to find, and 
Table 2. Maximal level of resistance of strains with mutations at 
/3-lactamase residue 71 
Maximal antibiotic concentration (mg/liter) 
at which colonies grew 
Benzyl- 6-Amino-
Amino Ampicillin penicillin penicillin 
acid 300C 37"C 300C 37"C 300C 37"C 
Gly >.500 Trace >.500 50 35 20 
Ala >.500 75 >.500 100 Trace Trace 
Val >.500 150 >500 175 75 Trace 
Leu >500 100 >.500 125 80 Trace 
De >.500 >.500 >500 >.500 90 40 
Met >.500 125 >.500 150 30 0 
Pro >.500 200 >.500 350 50 40 
Pbe 60 0 0 0 0 0 
Trp 0 0 0 0 0 0 
Tyr 0 0 0 0 0 0 
His >.500 >500 >500 >500 >250 >250 
Cys >.500 >500 >.500 >500 >250 100 
Ser >.500 >500 >500 >500 >250 >250 
Thr >.500 >.500 >500 >500 >250 >250 
Asn 270 Trace 210 Trace 55 Trace 
Gin 130 20 70 Trace 55 0 
Asp 0 0 0 0 0 0 
Glu 200 Trace 70 Trace Trace Trace 
Lys 0 0 0 0 0 0 
Ara 0 0 0 0 0 0 
Stop 0 0 0 0 0 0 
A > indicates that this value was the highest level of antibiotic 
tested. 
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may go untested in the phenotype screening, particularly 
when multiple sites are involved. Nearly equimolar mixtures 
of oligonucleotides can be obtained by careful synthesis (S. 
Horvath, personal communication) and then )lsed in cassette 
mutagenesis to generate the various mutations with known 
frequencies . In a Poisson distnbution the probability of finding 
a particular codon at least once among 101 colonies is 96%. As 
shown in Table 1, 94% (30/32) of the codons were observed one. 
or more times. The absence of two codons, therefore, was 
probably the consequence of a small sample size. 
In sequencing plasmids from 105 individual colonies we 
found none in which the 35-base-pair segment contained 
unexpected base substitutions. However, 14 frameshift mu-
tants resulting from single-base deletions or additions were 
observed (see Table 2). The 9 additions and deletions at 
restriction sites may occur during processing of the synthetic 
fragmept or during ligation; similar deletions have been 
observed, for example, in ligation of a synthetic fragment into 
the Pst I site of the gene for subtilisin (14). The other 5 
mutations that occur within the synthetic fragment probably 
result from imperfections in the DNA synthesis. None of the 
colonies containing plasmids with these frameshift mutations 
show any resistance to penam or cephem antibiotics. 
The antibiotic resistances of colonies containing the 19 
mutant J:l-lactama~es were initially determined by picking 
colonies and patching them onto agar plates with various 
levels of antibiotics. More accurate values were measured by 
spreading mutant colonies onto agar plates having a linear 
concentration gradient of antibiotics (see Table 2). This latter 
method gives consistently lower values for antibiotic resist-
ance, as in this case individual cells must establish colonies, 
whereas when colonies are picked and applied in patches 
many cells are initially present at a single site, allowing them 
to cooperate in iflactivating sufficient antibiotic to allow 
growth. Both sets of data are, however, useful, as colonies 
with mutants having low lactamase activity would be classi-
fied as inactive if only plating were used. In Table 2, colonies 
that grew when picked, but not when plated, are designated 
as having trace activity. 
The antibiotic resistance of colonies containing mu~t 
plasmids reflects many factors : plasmid replication, tran-
scription, stability and ease of translation of the mutant 
mRNAs, stability of the pre-J:l-lactamases in the cytoplasm, 
possible differences in the rate of processing and secretion, 
stability of the proteins in the peri plasm, and, finally, intrinsic 
enzymatic activity. With regard to the step~ from transcrip-
tion to translation, the codon used for a given amino acid at 
residue 71 did not alter observed antibiotic resistance ; in all 
cases, a given amino acid mutant confers the same level of 
antibiotic resistance regardless of which codon was used (see 
Table 1). 
Mutations may affect processing and secretion of proteins 
(34) and thereby alter the relative concentrations of mutant 
J:l-lactaffiases in the periplasm. Although mutants such as 
Thr-71-+ Serand Ser-70-+ Thr and the double mutant Ser-70 
-+ Thr, Thr-71 -+ Ser seem to be processed and secreted 
normally in Salmonella typhimurium (12), these mutations 
are unlikely to affect these processes as drastically as 
mutations such as Thr-71-+ Trp, Tyr, Lys; even in these 
cases, however, abundant processed protein is apparent in 
cells growing at 3o•c (see Fig. 2). 
Resistance to thermal denaturation and proteolysis can 
greatly influence the in vivo concentration of mutant proteins 
(12, 35). Analysis by protein blots (Fig. 2) for celllysates of 
colonies growing at 3o•c and 37•c show significant differ· 
ences in the concentrations of mutants. A band representing 
the precursor protein shows similar intensities for the mu-
tants and wild type; the presence of normal amounts of 
precursor proteins suggests that processing and secretion 
have not been drastically altered for the mutants. However, 
the amounts of protein in the periplasm vary greatly for the 
mutants as contrasted to wild type, particularly for cells 
growing at .37"C, indicating that the mutants are more 
susceptible to proteolysis than the wild-type enzyme. 
A surprising number of mutants with amino acid substitu-
tions at Thr-71 display lactamase activity; indeed, of the 19 
substitutions at residue 71 only 5 (Trp, Tyr, Lys, Arg, or Asp) 
give prpteins that confer no observable resistance to ampicil-
lin or benzylpenicillin. Enzymes with Gin, Glu, Asn, or Phe 
at residue 71 provide low-level resistance, but enzymes with 
all other amino acids at this site have high activity toward 
benzylpenicillin and ampicillin. Some preliminary conclu-
sions about structure-function relationships can be drawn 
from these data. Mutants having amino acids with charged or 
very large side chains at residue 71 have at best very low 
activity, otherwise both polar and nonpolar side chains seem 
compatible with appreciable activity . When 6-arninopenicil-
lanic acid is used to select for activity, mutants with amino 
acids having nonpolar side chains show decreased activity, 
whereas mutants with amino acids having polar side chains 
retain activity toward this antibiotic . All mutants show a 
dramatically decreased ability to confer resistance toward the 
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cephem antibiotics cephalothin and cephalexin. At 30"C, 
wild-type p..lactamase (Thr-71) confers resistance to at least 
100 mg/ liter while the mutant Thr-71-+ Ser confers resist-
ance only to low levels of the cephem antibiotics; at 37"C only 
wild-type enzyme provides observable resistance. Though 
we have yet to characterize fully the inherent catalytic 
activity of all the mutants at residue 71, some representative 
data for benzylpenicillin as substrate are, respectively, kc&! 
(sec- 1), Km (ji.M), kca1/Km (M-1-sec- 1), and relative values 
for kcat!Km as follows : wild-type enzyme, 2000,26,7.7 x 107; 
and 1; Thr-71-+ Ser, 300,21 , 1.6 x 107, and 0.21 (12); Thr-71 
-+ lle, 1530, 350, 4.4 x 107, and 0.57 (Y. H. Chang and 
J .H.R., unpublished results). 
Because many m1,1tants at residue 71, including those 
having amino acids with polar and nonpolar side chains, show 
appreciable activity toward penams, we conclude that Thr at 
71 is not essential for binding and catalysis, though it may 
perform some contributing role in these functions. However, 
residue 71 does play a very important role in the structural 
stability of the protein, as observed in the increased sensi-
tivity to proteolysis of all 19 mutants. The importance of 
branching at the p..carbon of Thr with a polar hydroxyl group 
and nonpolar methyl group is demonstrated, for example, by 
the increasing antibiotic resistance of cells growing at 37°C 
!'rovided by the series of enzymes with Gly < Ala < Leu < 
Val. The increased thermal and proteolytic sensitivity rela-
tive to wild type of the mutant Thr-71-+ Ser(12), lacking only 
the methyl group of Thr, further supports this view. The 
relatively high catalytic activities ofThr-71-+ Cys and Thr-71 
-+ Ser demonstrate the importance of the polar group. The 
reduced activity toward 6-aminopenicillanic acid of enzymes 
having amino acids at residue 71 with nonpolar side chains 
suggests that the side chains of residue 71 influence the 
hydrophobic or hydrophilic characteristics ofthe pocket that 
accommodates the substituent attached to the P..lactam ring 
of the substrates. This possibility is further emphasized by 
the lower activity of enzymes with Glu or Gin at residue 71 
toward benzylpenicillin (neutral , nonpolar substituent) than 
toward ampicillin (positively charged, polar substituent). 
All mutant enzymes confer on cells at best very low 
resistance toward cephalothin and cephalexin; this likely 
results from the inherently lower activity of p..lactamase 
against cephem antibiotics (36) and accords with results 
observed for mutations in other regions of the enzyme (37). 
This behavior also demonstrates the importance of the 
conserved residues at the catalytic site in providing an 
enzyme with high levels of catalytic activity and stability. 
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PROPOSITION I 
SITE SATURATION STUDIES OF THE 
DNA BINDING HELIX OF CAP 
AND ITS OPERATOR SEQUENCE 
142 
Background 
By interacting with specific base sequences in the DNA 
helix, proteins can bind to the operator regions of genes and 
exert the positive andjor negative control necessary for 
proper gene expression in cells. Recently, x-ray crystal-
lography has provided the three-dimensional structures for 
several DNA binding proteins including: the catabolite acti-
vator protein (1), the lambda cro repressor (2), a proteo-
lytic fragment of the lambda CI repressor (3), a proteolytic 
fragment of the phage 434 repressor (4), and the tryptophan 
repressor (5). From among the very dissimilar structures of 
these proteins, a common feature has emerged that may explain 
how proteins can recognize and bind to specific base sequen-
ces in the DNA helix. Each identical subunit of these 
dimeric proteins contains a helix-turn-helix structure in 
which one of these a-helices protrudes from the surface of 
each subunit. In the protein, these protruding helices are 
34 A apart and could align themselves with two successive 
major grooves on one face of the DNA double helix. Amino 
acid side chains extending from these helices could interact 
with specific arrangements of chemical groups in the major 
groove of the DNA helix and thereby provide the specificity 
these proteins require for binding to their operator sequenc-
es. This model has recently been verified by a solution for 
the crystal structure of phage 434 repressor bound to its 
operator sequence (4) . 
Due to the helical twist of DNA, the helix-turn-helix 
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structure will allow only three to five amino acid side 
chains to contact no more than three to five base pairs in 
the major groove of the DNA helix. Although limited to three 
to five sets of interactions for each subunit, DNA binding 
proteins can distinguish between very similar sequences and 
bind very tightly to the proper sequence. Because such 
functions must be accomplished by these limited interactions 
and because only four nucleotide bases and twenty amino acids 
occur naturally, one may expect to find a "code" for the 
interactions of proteins and DNA; this "code" would define 
what amino acid side chains could bind to which specific base 
pairs. Several possible bonding schemes have been proposed 
by which certain amino acid side chains could contact partic-
ular bases in the major groove of the DNA helix (6). For 
example, a glutamine or asparagine could simultaneously 
form hydrogen bonds with the N6 and N7 positions of adenine 
or interact with an adenine N6 or cytosine N4 while at the 
same time bind a thymine 04 or purine N7. Discrete bonding 
schemes have also been proposed for serine, arginine, and 
lysine (6). 
The catabolite activator protein (CAP) binds to operator 
regions of more than 20 E. coli genes when cyclic-AMP is 
present and stimulates their transcription (7). CAP can also 
repress transcription of some genes (8,9). The structure of 
the CAP-cAMP complex has been solved at 2.9 A resolution 
(1). Specific interactions have been proposed for binding of 
amino acid side chains of the F helix with specific base 
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groups in the major groove of the B-DNA helix (10). These 
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Studies of mutant CAP proteins and altered CAP binding sites 
support this model (11). For example, changing base pairs 57 
or 66 from GC and CG to AT and TA respectively requires a 
compensating change of Glu 181 to Lys, Leu, or Val in CAP 
( 11) • 
I propose to use site saturation (12) of CAP and its 
operator sequence to investigate the recognition code for the 
binding of this protein to specific base sequences. 
Proposal 
Effective site saturation studies require a selectable 
phenotype such that active mutants can be isolated from among 
large numbers of inactive mutants. B-Lactamase exhibits this 
type of selectable phenotype; the presence of active B-lacta-
mase provides resistance to penam and cephem antibiotics such 
that cells producing this enzyme can grow in the presence of 
145 
these antibiotics while all others perish (13). This activ-
ity allows one to isolate cells producing active mutants of 
this enzyme even when present only once among 106 or more 
inactive mutants. 
For the experiments proposed here, the B-lactamase gene 
will be placed under control of the lac promoter, which 
requires CAP to initiate transcription (14), such that this 
antibiotic selection can be used to isolate mutants of CAP 
that retain their ability to activate transcription. A 
synthetic insert containing the lac operon will be introduced 
into the Ssp I restriction site that immediately precedes 
the B-lactamase gene in pBR322. The lac operon is 123 base 
pairs in length (15), but 17 base pairs at the end of this 
segment will be omitted to maintain proper spacing between 
the promoter and the beginning of the structural gene. The 
following oligonucleotides will be synthesized, annealed, and 





- - CCGAAATGTGAAATAGCAAGGCCGAGCATACAACACACCTTAACACTCGCGTATTGTT 
...._____. 
Ava I 
The resulting fragment will be ligated into the Ssp I site of 
pBR322. This construction will probably interfere with the 
B-lactamase promoter already present - preventing the normal 
constitutive transcription (16); if not, this promoter region 
can be removed. 
If this construction is successful, E. coli cells con-
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taining the plasmid should grow in the presence of ampicillin 
only when cAMP is added to the media. The promoter may be 
slightly "leaky" such that some B- lactamase is produced; if 
low levels of resistance are observed, one could use either 
higher levels of ampicillin or more potent antibiotics, such 
as cephalexin. Note that two different Ava I sites have been 
included in the synthetic fragment; these sites will facili-
tate mutagenesis of the operator sequence. 
The gene for CAP (called the crp gene) has been cloned 
and expressed in pBR322 (17). The resulting plasmid (called 
pHA7) confers ampicillin but not tetracycline resistance to 
cells harboring the plasmid. Since the ampicillin gene will 
be placed under control of the lac operon, a constitutive 
selectable marker must be introduced into the plasmid . The 
following construction is proposed: 
EcoR I 
EcoR V + ,nr J Pvuii ka:/ 
Sma II 
The portion of the gene coding for the DNA binding 
domain of CAP has been synthesized to contain several conve-
nient restriction sites (T. Steitz, unpublished); this por-
tion of the CAP gene can be easily incorporated into the 
cloned, expressed gene. By combining this plasmid with 
plasmid pCKP described above, all the necessary elements 
for site saturation studies of both CAP and the operator 
sequence will be present in a single plasmid called pCRS. 
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The first experiment will be site saturation of Arg 
185. By finding a mutant that continues to initiate tran-
scription, we can eliminate residue 185 and base pairs -58 
and -65 from future studies. We could then concentrate on 
saturating the three amino acid residues and three base pairs 
involved in the sequence specific binding of CAP. If Arg 185 
cannot be replaced by any other amino acids, this residue 
will be left unchanged. 
I propose to simultaneously saturate residues 180, 181, 
and 188 from CAP and base pairs -55, -56, -57, -66, -67 and 
-68 from the operator DNA. 
The following mixture of sequences will be incorporated 
into Mlu I and Xho I sites in the CAP gene: 
CGCGTCAGGAAATTGGTCAGATTGTCGGCTTGTTCTXXXXXXACCGTGGGACGCATTCTGXXXATGC 
AGTCCTTTAACCAGTCTAACAGCCGAACAAGAXXXXXXTGGCACCCTGCGTAAGACXXXTACGAGCT 
The xxx sites will consist of codons for all twenty amino 
acids. Phosphoramidite derivatives of twenty nucleotide 
trimers will be used to incorporate these sequences in a 
single synthesis. This mixture will include 203 or 8000 
possible amino acid sequences. 
Since 8000 possible amino acid sequences are present, we 
must limit the number of operator sequences to keep this 
system workable. Therefore, 64 different oligonucleotides 
must be synthesized separately. The sequences will be: 
GCACTGCCCGAGGCAATTAATxxxAGTCGACT 
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These 64 sequences will contain different base sequences at 
the site marked xxx. Notice that the 3' ends of this 
sequence are self-complementary. For each individual 
sequence, the strands will be annealed and extended using the 
Klenow fragment of DNA polymerase I. This procedure will 
make all recognition sequences palindromic. By cleaving this 
fragment with Ava I restriction endonuclease, protruding 
5 1 ends will be produced. All 64 individual fragments can 
now be combined in equal amounts and ligated into a mixture 
of plasmids containing all possible amino acid sequences at 
residues 180, 181, and 188. The resulting plasmid mixture 
will contain 512,000 unique sequences. 
This mixture of plasmids will be used to transform 
E. coli and the resulting cells will be grown in the presence 
of cAMP and ampicillin. CAP mutants that can still initiate 
transcription will be resistant to ampicillin. The mutations 
in the protein and operator regions of plasmids from ampr 
colonies can then be identified by DNA sequencing. Since 
512,000 possible combinations exist, approximately 5 X 107 
kanamycin resistant cells (kanr is the constitutive selec-
table marker on pCRS) should be selected for ampicillin 
resistance; most of these cells should be ampicillin sensi-
tive. 
several problems may exist in these experiments. For 
example, particular CAP mutants may bind at sites present in 
the cell genome and, therefore, could be lethal to these 
cells. Similarily, recognition of specific altered operator 
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sequences by regulatory proteins already present in the cell 
could interfere with the results of the experiment. Also, 
some CAP mutants may bind to the operator region as desired, 
but fail to activate transcription such that these cells will 
be ampicillin sensitive. 
Even though all possible combinations of CAP and opera-
tor sequences may not be tested because of the problems 
listed above, emphasis should be placed on the altered pro-
tein and operator sequences that are obtained from these 
experiments. Even if only a few sets of interactions are 
found, the implications will be very exciting. 
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EFFECT OF SER --> THR MUTATIONS ON 
THE THERMAL STABILITY OF AN 
AMINOCYCLITOL-3 1 -PHOSPHOTRANSFERASE 
153 
Background 
Proteins exhibit a large variety of thermal stabilities; 
while some undergo irreversible denaturation below 50°c, 
others can maintain normal activity even above 90°C. Recent 
studies of mutant proteins containing single amino acid 
substitutions have shown that very minor changes in protein 
structure can have major effects on the stability of a pro-
tein (1). For example, the absence of a single methyl group 
in the Thr 71 --> Ser mutant of B-lactamase dramatically 
reduces the stability of the protein toward heat, pH, and 
proteolysis (2). Many examples exist for destabilization of 
proteins by single amino acid substitutions, but only a few 
exist for stabilization of proteins by specific amino acid 
substitutions. These examples include mutations that intro-
duce a disulfide bond (3), an ionic interaction (4,5), a 
hydrophobic interaction, (6) and an aromatic ring interaction 
(7). To stabilize a protein, very specific interactions must 
be generated in the three-dimensional structure of a protein; 
consequently, designing such mutations is difficult. 
Many interactions contribute to the stability of a 
protein including hydrogen bonds, ionic interactions, disul-
fide bonds, and hydrophobic interactions. By analyzing the 
amino acid sequences of ferredoxins, glucose 6-phosphate 
dehydrogenases, and lactate dehydrogenases from several 
mesophilic and thermophilic bacteria, several amino acid 
substitutionk that increase the thermal stabilities of pro-
teins have been identified (8). The substitutions observed 
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most frequently were Gly --> Ala, Ser --> Ala, Ser --> Thr, 
Lys --> Arg, and Asp --> Glu. The aliphatic indexes of 
proteins from thermophilic bacteria are consistently higher 
than those from mesophilic bacteria (9). These results 
indicate that hydrophobic residues play an important role in 
providing thermal stability to proteins. Since we have 
observed that the absence of a single methyl group in the Thr 
71 --> Ser mutant of B-lactamase results in a dramatic reduc-
tion in stability (2), I propose to study the opposite pos-
sibility : stabilization of proteins by substitution of Thr 
for Ser. 
In choosing a protein for such studies, two factors must 
be considered. First, temperatures ranging from 30°c to 
>60°C must be utilized; therefore, the protein of interest 
must be expressed in both mesophilic and thermophilic bac-
teria. Second, a selectable phenotype will be necessary for 
investigating large numbers of mutations. The aminocyclitol-
3'-phospotransferase from the transposable element Tn5, 
which confers kanamycin resistance to several bacteria (10), 
fulfills both of these requirements. By selecting cells 
containing random mutants of a related protein (an amino-
glycoside nucleotidyltransferase) for resistance to kanamycin 
in the themophile B. stearothermophilus at >60°C, two groups 
independently isolated mutants that were more stable than the 
wild type enzyme (4,5); both groups identified these muta-
tions as Asp 80 --> Tyr and Thr 130 --> Lys. 
Several different enzymes confer kanamycin resistance to 
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bacteria; these have been classified according to how they 
modify kanamycin (acetyltransferase, nucleotidyltransferase, 
and phosphotransferase) and where they·modify kanamycin 
(6'-amino, 3'-hydroxy, 4 1 -hydroxy, 2'-amino, 3 1 -amino, or 2" 
hydroxy group) (11). The structure of kanamycin is shown 





Of the three types of resistance proteins, the aminoglycoside 
(or aminocyclitol) 3 1 -phosphotransferases (APH's) are best 
characterized. 
I propose to study the effect of Ser --> Thr mutations 
on the thermal stability of the aminoglycoside phosphotrans-
ferase encoded by the transposable element Tn5. 
Proposal 
The gene for the aminocyclitol-3'-phosphotransferase 
from Tn5 has been cloned into the Hindiii - BamHI site of 
pBR322; this plasmid is called pGR417 (10). To generate a 
plasmid that will replicate in both E. coli and B. stearo-
thermophilus, a Cla I fragment (approximately 2 Kb long) from 
plasmid pBST 1, which is a plasmid that occurs naturally in 
B. stearothemophilus (5), will be cloned into theNar I sites 
of pGR417; this plasmid will be called pTTS . Similar con-
structions containing the aminoglycoside nucleotidyltrans-
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ferase have been successfully propagated in both E. coli and 
B. stearothermophilus (5). 
The plasmid described above could be used to transform 
B. stearothermophilus by using previously reported procedures 
( 5) • By growing transformed cells at various temperatures, 
the maximum temperature at which the APH protein confers 
kanamycin resistance could be determined; temperatures above 
this value will be referred to as nonpermissive temperatures. 
The Tn5 encoded APH has 10 serine residues (10). Of 
these 10 residues, only the Ser at residue 36 is conserved 
among the 4 related APH enzymes from Tn5, s. aureus, ~ 
fradiae, and Tn903 (12) as shown in the figure below (from 
reference 10). 
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This residue, therefore, will be mutated separately to 
determine whether it is essential for activity. At the other 
9 residues, a variety of amino acids are present in the four 
APH proteins. The following experiments are proposed for 
studying the effect of changing these 9 serine residues to 
threonine. 
By utilizing unique Hindiii and BamHI restriction sites 
in the pTTS plasmid construction described above, a gapped 
duplex can be generated as shown below; this gap encompasses 
the entire kanr gene. 
o:, 41«eat with :;:,... isolate ~ denature 
Hindiii long wiU 
JluHI trapent bue _,o.: prrs 
0 Sea I di«e.t bolate circular pl&aid with ) denature ~ Sea I with lase 
prrs 
A method for producing such gapped duplexes has been reported 
previously (13). 
Various Ser --> Thr mutations can be generated simulta-
neously by oligonucleotide-directed mutagenesis (14,15) of 
this gapped duplex. Seven oligonucleotides will be synthe-
sized to introduce the nine mutations. All seven of these 
these oligonucleotides will be annealed simultaneously to the 
gapped duplex, extended with the Klenow fragment of DNA 
polymerase I, and ligated together with T4 DNA ligase. If 
the efficiency of mutagenesis is approximately 3% per site, 
27% of the resulting plasmids will introduce single site 
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mutations and 0.07% will introduce double mutations. This 
estimate assumes that the frequencies of mutation at each 
site will be additive, which is unclear. Therefore, large 
numbers of colonies must be screened in the experiments 
described below. Alternate methods for introducing the 
mutations more efficiently should also be investigated. 
The mixture of plasmids resulting from oligonucleotide-
directed mutagenesis will then be used in two experiments: 
(i) direct screening for increased thermal stability and (ii) 
random mutagenesis to search for second-site mutants with 
enhanced thermal stability. 
For the first experiment, previously described proce-
dures (5) will be used to transform B. stearotherrnophilus 
with the mixture of mutagenized plasmids. The transformation 
mixture will be plated onto agar plates containing kanamycin 
and incubated slightly above the permissive temperature. 
Plasmid would then be isolated from colonies that grow under 
these conditions. DNA sequencing of these plamids will be 
used to identify any Ser --> Thr mutations that enhanced the 
thermal stability of APH. 
For the second experiment, the mixture of mutagenized 
plasmids will be used to transform E. coli and these cells 
will be grown in broth at 30°C. Plasmids prepared from this 
mixture will be used to generate circular gapped duplexes as 
described above. By using dNTP's containing a small propor-
tion of a-thionucleotides and the Klenow fragment of DNA 
polymerase I, high frequencies of random point mutations 
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would be generated in the kanr gene (16); as a control, the 
same experiment will be performed on gapped heteroduplexes 
with the wild type sequence. These plasmids would be used to 
transform B. stearothermophilus; the transformation mixtures 
will be plated on agar containing kanamycin and incubated at 
temperatures well above the permissive range. If the control 
experiment produces as many colonies as the reversion experi-
ment, the cells should be incubated at higher nonpermisive 
temperatures. If equal numbers of colonies are still pre-
sent, mutations from the control experiment could be identi-
fied and removed from the Ser --> Thr experiment by screening 
the colonies with synthetic oligonucleotides. If this ap-
proach becomes unworkable, individual Ser --> Thr mutations 
could be isolated from E. coli at 30°C and used in reversion 
experiments. 
The experiments described here are designed to test two 
possible mechanisms for increasing the thermal stability of 
proteins. The first possibility, stabilization of proteins 
by substitution of one or more Ser residues by Thr, would 
seem unlikely; however, such substitutions are observed when 
comparing proteins from mesophilic and thermophilic bacteria 
(8,9). The second set of experiments are designed to test 
for second site mutations that might complement the initial 
Ser --> Thr mutation. Several problems may exist in these 
experiments since such large numbers of mutations will be 
studied; however, the ability to select for resistance at 
several nonpermissive temperature will allow one to select the 
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most stable proteins from among 106 or more less stable 
mutants. Methods such as these that utilize phenotypic 
selections in thermophiles should have many general applica-
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PROBING THE FLEXIBILITY OF THE 
N-TERMINAL ARMS AND a-a TURN REGIONS 
OF LAMBDA REPRESSOR HEADPIECE BY NMR 
164 
Background 
Lambda repressor binds to specific base sequences in two 
operator regions of lambda phage and subsequently represses 
transcription of lambda phage proteins while promoting its 
own transcription (1,2). This activity maintains the lyso-
genic state of lambda phage and prevents super-infection 
with other lambda phage DNA. The repressor protein binds as 
a dimer of identical subunits to an operator region that also 
has approximate two-fold symmetry (3,4). Each subunit of the 
dimeric protein contains two domains (4); by treating lambda 
repressor with papain, one can produce an N-terminal fragment 
composed of the first 92 amino acids of the protein (5,6). 
This fragment (commonly called the lambda "headpiece") binds 
operator DNA as a dimer and exerts both positive and negative 
control on flanking genes, as does the intact enzyme (5,6). 
The crystal structure of the headpiece of lambda repres-
sor shows that this domain contains five a-helices (7), two 
of which (a-2 and a-3) form a helix-turn-helix structure that 
apparently is able to contact specific bases in the major 
groove of the DNA helix (7). A proposed model for the bind-
ing of lambda repressor headpiece to DNA is shown below (from 
reference 7). 
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Similar helix-turn-helix structures exist in lambda cro 
repressor (8) and catabolite activator protein (9) as well as 
many other DNA binding proteins (10,11); this structure 
probably represents a general motif by which proteins can 
bind to specific sequences of DNA. 
However, lambda repressor differs from cro repressor and 
CAP in several ways. The a-a turn between helix 2 and 3 
contains four rather than three amino acids as in CAP and cro 
protein (7). The lambda repressor has N-teminal arms that 
apparently "wrap" around the DNA to make contacts on the 
opposite side of the helix (12). The biological activity of 
lambda repressor is also unique in that this protein exerts 
both positive and negative control from the same operator 
region (1,2). Interestingly, a mutation in the four residue 
a-a turn (Gly 43 --> Arg) results in a protein that can still 
exert negative control on flanking genes, but can no longer 
exert positive control (13). 
I propose to study the dynamics of the N-terminal arm 
and a-a turn of the lambda repressor headpiece. By incorpo-
rating 13c and 15N spin labels at specific positions in the 
headpiece of lambda repressor, NMR could be used study local 
motions in these regions of the protein. 
Proposal 
NMR provides a sensitive probe for local motions in 
macromolecules, especially when spin labels can be placed at 
specific positions. Many examples of such studies exist 
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(14,15). 
By chemically synthesizing a peptide, spin labels could 
be incorporated into very specific positions in the 
sequence. Modern methods for peptide synthesis can be used 
to synthesize peptides composed of 70 or more amino acids 
(16); however, this length may may vary from 50 to 150 amino 
acids depending on the sequence (16). I propose to 
incorporate the following spin labels into the headpiece of 
lambda repressor (see figure below) by synthesizing a peptide 
92 residues long. Although synthesis of the entire headpiece 
is desirable, a peptide containing the first 75 amino acids 
may also be sufficient for these experiments if the 92-mer 
cannot be synthesized. 
Ser 1 Thr 2 Lys 3 
Met 40 Gly 41 Met 42 Gly 43 Val 47 
The isotopically labelled amino acids required for synthesis 
of this molecule are commercially available. Identification 
of the 13c resonances of the peptide should be straitfor-
ward. Although minor changes in the chemical shifts of these 
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nuclei may occur as a result of the conformation of the 
peptide, reference shifts determined for these residues in 
short, flexible peptides are listed below (17,18). 
Enriched Shift 
Residue Nucleus (in :Q:Qm with res:Qect to dioxane) 
Ser 1 B-13c -5.4 
Lys 3 a-13c -12.9 
Gly 41 a-13c -23.95 
Met 42 E-13c -52.3 
Gly 43 a-13c -23.9 
Val 47 a-13c -6.9 
The 15N labels will assist in distinguishing between the 
resonances for Gly 41 and Gly 43 and for identifying the Ser 
1 resonance. Proton coupling patterns should unambiguously 
identify the remaining Gly 41, Lys 3, and Met 42 resonances. 
Relative relaxation rates will be determined for (i) 
free peptide in solution, (ii) peptide in the presence of 
non-operator DNA, and (iii) peptide in the presence on oper-
ator DNA. The following synthetic oligonucleotide segments 









The magnitude of the relaxation rates will depend partly on 
the conditions used in the measurements; therefore, these 
conditions should be as consistent as possible. In a study 
of myoglobin, T1 values (MS) at 67.9 MHz of the carbon atoms 
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in a lysine residue that lies in an a-helix were as follows: 
a-13c = 170 ± 8, E-13c = 734 ±so (14). 
In the absence of operator DNA, the N-terminal residues 
of the lambda headpiece will probably rotate freely. The 
first three residues were not observed in the crystal struc-
ture of the lambda headpiece indicating that these residues 
are disordered in the crystal lattice (7). The relaxation 
rates for the resonances of these nuclei should reflect this 
free rotation. When the peptide is bound to operator DNA, 
however, the relaxation rates should decrease dramatically. 
The a-a turn between helices 2 and 3 of lambda repressor 
is probably quite rigid. However, in solution, peptides 
frequently are more disordered than the intact protein (19). 
Changes in the mobility of this turn upon binding to non-
operator andjor operator DNA should be reflected in the 
relaxation rates of the labeled nuclei of residues 40, 41, 
and 42. The relaxation rate of Val 47 will act as a con-
trol; this residue should be rigidly held by the a-3 helix 
and, therefore, the relaxation rate of this nucleus should 
not change significantly for the three conditions described 
above. 
Several additional experiments could also be performed 
using the labeled peptide described above. Analysis of the 
chemical shifts may indicate the nature of the local environ-
ments in which the labelled nuclei exist for the various 
DNA-peptide complexes. NOE experiments with the 3lp nuclei 
of the phosphate backbone of operator and non-operator DNA 
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may help determine the proximity of the labeled residues to 
the DNA phosphates. Heteronuclear 2-D NMR or magnetization 
transfer experiments may allow one to utilize proton reso-
nances of the labeled residues. 
The primary purpose of these experiments, however, is to 
determine the relative mobilities of the N-terminal arm and 
the a-a turn of lambda repressor headpiece when the peptide 
is free in solution, nonspecifically bound to non-operator 
DNA, and specifically bound to operator DNA. The N-terminal 
arm is a unique feature of lambda repressor. These residues 
probably function only to stabilize the specific complex; 
however, the behavior of these residues in the nonspecific 
complex have not been investigated. Determining the mobility 
of the .a-a turn between helices 2 and 3 in lambda repressor 
whether flexible or rigid, will have implications in the 
study of the behaviour of this structural unit in recognition 
of specific sequences in the DNA helix. The a-d turn of 
lambda repressor is especially interesting since the Gly 43 
--> Ala mutant was found to exert normal negative control but 
not positive control on flanking genes. 
Problems may exist in the experiments described above. 
For example, accurate values for relaxation rates can be 
difficult to obtain; several factors can introduce errors 
into individual experiments. Incorporating an a-13c into Val 
47 should be useful as an internal control for estimating 
such errors; Val 47, which lies in the a-3 helix and faces 
away from the DNA helix, should be rigid and, therefore, the 
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relaxation rates of this nucleus should be relatively con-
stant for the various conditions. 
Despite possible difficulties, the experiments described 
here should be very effective for determining whether the 
N-terminal and a-a turn regions of the DNA helix are flexible 
or rigid when the protein is (i) free in solution, (ii) 
nonspecifically bound to non-operator DNA, and (iii) specif-
ically bound to operator DNA. 
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EFFECTS OF FLANKING SEQUENCES ON 
FACILLITATED DIFFUSION OF EcoRI 
174 
Background 
Although proteins that bind to specific base sequences 
on the DNA helix must search for their target sites in cells 
from among >107 non-target sites, such proteins can very 
rapidly locate their recognition sequences. A second order 
rate constant of 1010 M-1s-1 was observed for binding of lac 
repressor to a lac operator that was inserted into bacterio-
phage lambda DNA (1); yet, the second order rate constant for 
a one step diffusion-controlled interaction between the 
repressor and operator should be only 107 or 108 M-1s-1 (2). 
Apparently, DNA binding proteins can surpass the diffusion 
control limit by first binding to the DNA helix nonspecifi-
cally and then diffusing along the helix to search for its 
recognition site. This mechanism is commonly called facil-
litated diffusion. By utilizing such a mechanism, the mono-
tony of the DNA helix is transformed from an obstacle into 
an asset for rapid location of specific sequences of base 
pairs from among many sequences. 
Four mechanism have been proposed for facilitated 
diffusion (2). The first two involve positionally uncorrela-
ted sites: (i) macroscopic dissociation and reassociation 
between positionally uncorrelated sites and (ii) transfer of 
the protein between different segments of the DNA strand. 
The second two mechanisms involve positionally correlated 
sites: (iii) microscopic dissociation and reassociation 
(hopping) and (iv) sliding along the contour length of the 
double helix. Presently, several studies suggest that ~cil-
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itated diffusion proceeds via one of the positionally cor-
related mechanisms (3,4), although a positionally uncorrela-
ted mechanism may function in cooperation with a positionally 
correlated mechanism (5,6,7). 
Several restriction enzymes locate their recognition 
sites by facilitated diffusion in vitro at low ionic 
strengths (4,8) such that the rate of cleavage increases as 
the lengths of DNA segments flanking the recognition site 
increases; the mean diffusion length is approximately 1000 
base pairs in 1 mM MgC12 for EcoRI. However, this rate 
enhancement is very sensitive to the ionic strength of the 
solution; above ionic strengths of approximately 0.2, no rate 
enhancement occurs (4,8). 
Implicit in the discussion of facilitated diffusion by 
a positionally correlated mechanism is a regularity in the 
structure of the double helix; for a DNA binding protein to 
move freely along the helix, many identical, closely spaced 
sites must exist. Therefore, facilitated diffusion by a 
positionally correlated mechanism may be affected by local 
distortions in the DNA helix. For some resriction enzymes, 
flanking sequences are known to affect the rate of cleavage, 
although such effects may or may not result from differences 
in facilitated diffusion. Several distortions are known to 
occur due to particular arrangements of bases in the DNA 
helix (9,10). I propose to stud¥ the effect of sequence 
induced variations in the double helix on facilitated dif-
fusion for EcoRI. 
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Proposal 
The proposed experiments will require an effective and 
general assay. Two approaches could be used. First, one 
EcoRI site could be placed at one end of a long double-
stranded DNA segment; a variety of sequences could be placed 
in front of this site and the absolute rate of cleavage could 
be determined for various constructions. The second approach 
is to place an EcoRI site on each end of a long double-
stranded DNA segment; a variety of sequences could then be 
placed in front of one of these sites and the relative rates 
of cleavage at the two sites could be determined. An assay 
that measures relative rates of cleavage for sites containing 
normal and altered flanking sequences would probably be more 
reliable than measuring and comparing absolute rates of 
cleavage for different fragments since the purity and quality 
of DNA and protein as well as minor variations in the condi-
tions could cause significant errors in absolute rates. The 
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For determining the relative rates of cleavage for these 
two EcoRI sites, the following procedure is proposed. First, 
the plasmid will be digested with Xho I and radiolabeled 
using [a-32p]dTTP and the large (Klenow) fragment of DNA 
polymerase I. This linear fragment will then be treated with 
low concentrations of EcoRI at low ionic strength (- 0.1) and 
let react for various time periods. The resulting mixtures 
of fragments will be loaded onto a 20% polyacrylamide gel and 
electrophoresed. Cleavage of one site will produce a frag-
ment 20 bases long and cleavage at the other site will pro-
duce a fragment 25 bases long. An audioradiogram of the gel 
will be obtained and the relative quantities of the two 
fragments will be determined using a densitometer. The 
relative quantities of the two fragments should reflect the 
relative rates of cleavage at the two sites. If the rates of 
cleavage at the two sites differ significantly in this con-
struction, an alternate construction may be necessary or a 
new assay utilizing absolute rates of cleavage could be 
developed. 
To test the effects of flanking sequences on facil-
itated diffusion, the following synthetic oligonucleotides 
could be incorporated into the Xho I - Hindiii sites: 
I TCGAG/ /ATATATATATATATATATATA 
C/ /TATATATATATATATATATATTCGA 
II TCGAG/ /GCGCGCGCGCGCGCGCGCGCA 
C/ /CGCGCGCGCGCGCGCGCGCGTTCGA 
III TCGAG/ /ATATATGCGCATATATGCGCATATAT 
C/ /TATATACGCGTATATACGCGTATATATTCGA 
178 
IV TCGAG/ /GTGTGTGTGTGTGTGTGTGTA 
C/ /CACACACACACACACACACATTCGA 
V TCGAG/ /CAAAATGTCAAAAAATAGGCAAAAAATGCCAAAAATCA 
C/ /GTTTTACAGTTTTTTATCCGTTTTTTACGGTTTTTAGTTCGA 
VI TCGAG/ /GAATTTCGAAATTCCGAAATTCGGGAATTTA 
C/ /CTTAAAGCTTTAAGGCTTTAAGCCCTTAAATTCGA 
VII TCAG/ /GTGTGTGTGTGTGTGTACACACACACACACACACGTACGTA 
C/ /GGTTGGTTGGTTGGTTAACCAACCAACCAACCTGCATGCATTCGA 
The first six sequences could probably be cloned into 
the plasmid and grown in E. coli if desired. Alternatively, 
these fragments could be ligated into plasrnids and the resul-
ting DNA could be used directly; this latter approach is the 
only one that could be used for sequence VII. 
Sequences I - III will study the effects of differences 
in melting and hydration of the minor groove. The (AT)n 
sequences are easily melted and their minor grooves are 
hydrated in a very orderly manner (10). The (GC)n sequences 
are not easily melted and their minor grooves are hydrated 
very poorly. Sequences III and IV are intermediate and could 
help distinguish whether a decrease in rate is due to dif-
ferences in hydration or melting. 
Sequence V should introduce a large bend into the DNA 
fragment, perhaps as much as 40° to so 0 (9). 
Sequence VI would introduce four sites that contain 5 
out of 6 bases from the recognition sequence of EcoRI. The 
enzyme may stall at sequences similar to its recognition 
sequence. 
Sequence VII will introduce a cruciform structure into 
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the helix. 
By measuring the ratio of the labeled 20 and 25 base 
segments obtained from digestion with EcoRI at various time 
points, as discussed above, the preference for a particular 
site could be determined. The enzyme may simply stall at the 
perturbed region of the helix or it may dissociate from the 
helix. These two possibilities may be distinguishable by 
carefully measuring the absolute rate of cleavage at the 
nonperturbed site. The rate of cleavage at this site should 
be reduced if the enzyme stalls since the concentration of 
free EcoRI will be lowered; the magnitude of this reduction 
in rate will depend on how long the enzyme stalls. The rate 
of cleavage at the non-perturbed site will either remain the 
same or be enhanced if the perturbed region of the helix 
causes dissociation of the enzyme from the nonspecified 
complex; an enhanced rate would occur if this dissociation 
is greater than occurs after cleavage of an EcoRI site. 
If the ratio of cleavage at the two sites does not 
change for the various DNA constructions, the results would 
indicate that either (i) facilitated diffusion is more 
positionally uncorrelated than previously expected (4,8) or 
(ii) the nature of the nonspecific complex is less dependent 
on the structure of the DNA helix than previously proposed 
(2,3,6). 
The assay system presented here is quite general and 
could be used to test many different flanking sequences. 
Other restriction enzymes could also be tested. 
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INVESTIGATIONS OF IN VIVO AND IN VITRO 
MISMATCH REPAIR IN YEAST 
183 
Background 
The existence of mechanisms by which cells can repair 
mismatched base pairs in DNA was originally proposed to 
explain gene conversion in genetic recombination (1). Since 
then, numerous studies have been directed toward elucidating 
the nature of mismatch repair (2,3). Several mutant strains 
' of E. coli that exhibit deficiencies in mismatch repair have 
been isolated (3,4,5). These cells exhibit "mutative" pheno-
types in which spontaneous mutations occur at much higher 
frequencies than in wild type cells. Such studies indicate 
that for cells to maintain their genetic integrity, they must 
correct mismatches that arise from imperfections in replica-
tion and other cell processes. However, for a repair system 
to be effective, strand discrimination is necessary such that 
mismatches will be converted back to the original base pair. 
In E. coli, this discrimination apparently arises as a result 
of methylation (2,6,7); the newly synthesized strand will not 
be methylated and, therefore, a mechanism that repairs only 
the unmethylated strand will exhibit the necessary discrim-
ination. Recent results from cell free extracts of E. coli 
that are capable of mismatch repair strongly supports this 
scheme (8). 
Although such studies are rapidly elucidating many 
aspects of prokaryotic mismatch repair, little is known about 
such processes in eukaryotes. Although genetic studies have 
strongly suggested that mismatch repair does exist in eukar-
yotic organisms (9), only recently has the first direct 
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analysis been reported (10). In this study, heteroduplex 
plasmids containing small insertions were used to transform 
yeast; analysis of plasmids derived from tranformed clones 
indicated that one site was repaired in 85% of the clones and 
the second site was repaired in greater than 97% of the 
clones. 
I propose to develop an efficient assay to investigate 
mismatch repair in yeast in vivo and possibly in vitro. 
Proposal 
I propose to use four different mutants of B-lactamase 
to probe mismatch repair in yeast (S. cerevisiae). Two of 
the mutants are already available, Ser 70 --> Thr (AGC --> 
ACC) (11) and Lys 73 --> Arg (AAA --> AAG) (12), and two will 
be produced by standard techniques for oligonucleotide-
directed mutagenesis (13), Met 1 --> Thr (ATG --> AGC) and 
Ile 279 --> Asn (ATC --> AAC) ; the first two mutants are 
inactive and the second two should also result in an amps 
phenotype. 
Each of these mutations will be incorporated into 
plasmid pJDB207 (14}. This is 6.9 Kb plasmid that contains 
the entire pBR322 sequence as well as an origin of replica-
tion for yeast and a Leu2 gene (which is a selectable marker 
for Leu2- yeast strains). This plasmid will replicate in 
both E. coli and yeast. The mutant B-lactamase genes dis-
cussed above will be introduced into Ssp I and Sal I sites of 
pJDB207. 
Using these plasmids, heteroduplexes will be generated 
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plasmids resulting from the four 
mutants described above will then be used to transform 
s. cerevisiae. Plasmid derived from individual colonies will 
be isolated and used to transform E. coli. The transformed 
E. coli cells will be grown on plates containing tetracycline 
or ampicillin and the ratio of ampicillin:tetracycline resis-
tant colonies will be determined. If mismatch· repair did not 
occur, this ratio should be 1:2 for ampr:tetr colonies. If 
all of the mismatches were corrected, 50% of the plasmids 
derived from individual yeast colonies should give ratios of 
0:1 and 50% should give ratios of 1:1. If mismatch repair 
occurs only part of the time, plasmids derived from different 
individual colonies will give all three ratios of 1:2, 0:1, 





hetero4uplex ~ 0 
pl&aaid 
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Four different mutants are used since we might expect certain 
mismatches are apparently to be repaired more readily than 
others. The heteroduplexes described above will test 4 
different transitions and 4 different transversions. Notice 
also that since both strand are used in generating the 
duplexes, strand discrimination will not interfer with the 
results of these experiments. 
If the results from these experiments indicate that 
mismatch repair is occurring as one would expect, new hetero-
duplex plasmids will be generated as described previously. 
However, two different mutant plasmids will be used to gen-
erate the heteroduplex rather than one mutant and one wild 
type plamid; this will produce plasmids that contain two 
mismatches rather than one. Four constructions are pro-
posed: (i) Ser 70 --> Thr & Lys 73 --> Arg, (ii) Met 1 --> 
Thr & Ser 71 --> Thr, (iii) Ser 70 --> Thr & Ile 279 --> Asn, 
and (iv) Met 1 --> Thr & Ile 279 --> Asn. These construc-
tions will contain mismatches separated by 9, 209, 626, and 
833 base pairs respectively. The resulting heteroduplex 
plasmids will be used in the same experiments described 
above. 
These experiments should indicate whether the two mis-
matches are repaired independently or together. Proposed 
mechanisms for repair generally invoke production of a gap in 
the DNA helix which is then repaired (2); the size of the gap 
is uncertain and possibly quite variable. The experiments 
described here should indicate the size of the gap. If the 
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repair events are not independent (i.e~ the gap covers both 
sites), no ampicillin resistant colonies will be obtained. 
If the events are entirely independent, the fraction of yeast 
colonies containing plasmids that produce 1:1 ratios of 
ampr:tetr phenotypes in E. coli will be the product of the 
fractions obtained for the two heteroduplexes containing the 
corresponding single mismatched base pairs; if repair occurs 
100% of the time, 25% of the yeast colonies should contain 
plasmids that produce 1:1 ratios of tetr:ampr phenotypes 
in E. coli. If the observed fractions are not the product of 
the two fractions from the individual events, the events are 
either partially independent and partially non-independent or 
strand discrimination is occurring, although this seems 
unlikely since both strands were originally derived from the 
same E. coli strain. 
For the heteroduplex constructions containing two mis-
matches as described above, if gaps are produced in the 
repair of heteroduplexes, one might expect repair of the Ser 
70 --> Thr & Lys 73 --> Arg plasmids to be frequently non-
independent events since they are only 9 base pairs apart. 
If the gap forms only on one side of the mismatched bas~, 
both independent and non-independent repair will be observed, 
possibly even when the mismatches are only 9 bases apart. 
For the Met 1 --> Thr & Ile 279 --> Asn constructions, the 
mismatches are much further apart (833 bp) and, therefore, 
may be repaired independently unless the gap that forms is 
very large. 
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If the repair events are sometimes independent for one 
of the heteroduplex constructions, this assay would be quite 
useful for determining the activity of an in vitro mismatch 
repair system. Ideally, one could simply treat plasmid with 
cell extract, re-isolate the plasmid, transform E. coli, and 
then selecting for ampicillin resistance; ampr phenotypes 
would only be observed if mismatch repair had occurred. 
However, since replication may not occur in an in vitro 
system, unrepaired heteroduplexes could be repaired after 
incorporation into E. coli and thereby produce an ampr pheno-
type. Mutant strains of E. coli dificient in mismatch repair 
(5) could possibly be used to avoid such problems. This 
possibility can be easily tested by transforming these 
E. coli strains with the various heteroduplex plasmids. 
Recently, a method was reported for preparing cell free 
extracts that were capable of recombination (15). I propose 
to use the same preparation to screen heteroduplexes for 
mismatch repair. An assay that utilizes heteroduplexes 
containing two mismatched base pairs would provide a very 
sensitive screen for mismatch repair. Such a system could 
eventually help in isolating and characterizing the compo-
nents of mismatch repair in yeast. 
Many other experiments are also possible by utilizing 
the assay system described here. For example, several DNA 
repair systems are induced by stress (16); one could measure 
mismatch repair in cells after various forms of stress such 
as heat shock and UV irradiation. Also, large numbers of 
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mutant strains of yeast have been isolated, some of which are 
deficient in DNA repair systems induced by stress (16); 
one could test for mismatch repair in these strains as well. 
Another interesting experiment would be to generate double 
mismatch heteroduplexes as described previously, except 
obtain one of the mutant plasmids from a dam- strain of 
E. coli (17); in this case one strand will not be methylated 
and one will. One could then determine if methylation can 
give rise to strand discrimination in yeast. 
The experiments described here should be quite useful 
for studying mismatch repair systems in yeast. Although 
substantial amounts of genetic data exist on DNA repair, very 
little is known about the biochemistry of these processes. 
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